<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy - Virgili, G - 2015 | Cochrane Library</title> <meta content="Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy - Virgili, G - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008081.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy - Virgili, G - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008081.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008081.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy" name="citation_title"/> <meta content="Gianni Virgili" name="citation_author"/> <meta content="University of Florence" name="citation_author_institution"/> <meta content="gianni.virgili@unifi.it" name="citation_author_email"/> <meta content="Francesca Menchini" name="citation_author"/> <meta content="University of Udine, Azienda Ospedaliero‐universitaria di Udine" name="citation_author_institution"/> <meta content="Giovanni Casazza" name="citation_author"/> <meta content="Università degli Studi di Milano" name="citation_author_institution"/> <meta content="Ruth Hogg" name="citation_author"/> <meta content="Queen's University Belfast" name="citation_author_institution"/> <meta content="Radha R Das" name="citation_author"/> <meta content="Royal Victoria Hospital" name="citation_author_institution"/> <meta content="Xue Wang" name="citation_author"/> <meta content="Johns Hopkins Bloomberg School of Public Health" name="citation_author_institution"/> <meta content="Manuele Michelessi" name="citation_author"/> <meta content="Fondazione G.B. Bietti per lo studio e la ricerca in Oftalmolologia‐IRCCS" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD008081.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/01/07" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008081.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008081.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008081.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Diabetic Retinopathy [*complications]; Diagnostic Errors; Macular Edema [*diagnosis, etiology, pathology]; Randomized Controlled Trials as Topic; Retina [pathology]; Selection Bias; Sensitivity and Specificity; Tomography, Optical Coherence [*methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008081.pub3&amp;doi=10.1002/14651858.CD008081.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="na56WA6j";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008081\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008081\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008081.pub3",title:"Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy",firstPublishedDate:"Jan 7, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=na56WA6j&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008081.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008081.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008081.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008081.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008081.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008081.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008081.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008081.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008081.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008081.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5728 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008081.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-sec-0079"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-sec-0031"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-sec-0053"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-sec-0069"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/appendices#CD008081-sec-0084"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/table_n/CD008081StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/table_n/CD008081StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Diagnostic</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information#CD008081-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Gianni Virgili</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information#CD008081-cr-0003">Francesca Menchini</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information#CD008081-cr-0004">Giovanni Casazza</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information#CD008081-cr-0005">Ruth Hogg</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information#CD008081-cr-0006">Radha R Das</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information#CD008081-cr-0007">Xue Wang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information#CD008081-cr-0008">Manuele Michelessi</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information/en#CD008081-sec-0096">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 07 January 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008081.pub3">https://doi.org/10.1002/14651858.CD008081.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008081-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008081-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008081-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008081-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008081-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008081-abs-0001" lang="en"> <section id="CD008081-sec-0001"> <h3 class="title" id="CD008081-sec-0001">Background</h3> <p>Diabetic macular oedema (DMO) is a thickening of the central retina, or the macula, and is associated with long‐term visual loss in people with diabetic retinopathy (DR). Clinically significant macular oedema (CSMO) is the most severe form of DMO. Almost 30 years ago, the Early Treatment Diabetic Retinopathy Study (ETDRS) found that CSMO, diagnosed by means of stereoscopic fundus photography, leads to moderate visual loss in one of four people within three years. It also showed that grid or focal laser photocoagulation to the macula halves this risk. Recently, intravitreal injection of antiangiogenic drugs has also been used to try to improve vision in people with macular oedema due to DR. </p> <p>Optical coherence tomography (OCT) is based on optical reflectivity and is able to image retinal thickness and structure producing cross‐sectional and three‐dimensional images of the central retina. It is widely used because it provides objective and quantitative assessment of macular oedema, unlike the subjectivity of fundus biomicroscopic assessment which is routinely used by ophthalmologists instead of photography. Optical coherence tomography is also used for quantitative follow‐up of the effects of treatment of CSMO. </p> </section> <section id="CD008081-sec-0002"> <h3 class="title" id="CD008081-sec-0002">Objectives</h3> <p>To determine the diagnostic accuracy of OCT for detecting DMO and CSMO, defined according to ETDRS in 1985, in patients referred to ophthalmologists after DR is detected. In the update of this review we also aimed to assess whether OCT might be considered the new reference standard for detecting DMO. </p> </section> <section id="CD008081-sec-0003"> <h3 class="title" id="CD008081-sec-0003">Search methods</h3> <p>We searched the Cochrane Database of Systematic Reviews (CDSR), the Database of Abstracts of Reviews of Effects (DARE), the Health Technology Assessment Database (HTA) and the NHS Economic Evaluation Database (NHSEED) (<i>The Cochrane Library</i> 2013, Issue 5)<i>,</i> Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to June 2013), EMBASE (January 1950 to June 2013), Web of Science Conference Proceedings Citation Index ‐ Science (CPCI‐S) (January 1990 to June 2013), BIOSIS Previews (January 1969 to June 2013), MEDION and the Aggressive Research Intelligence Facility database (ARIF). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 25 June 2013. We checked bibliographies of relevant studies for additional references. </p> </section> <section id="CD008081-sec-0004"> <h3 class="title" id="CD008081-sec-0004">Selection criteria</h3> <p>We selected studies that assessed the diagnostic accuracy of any OCT model for detecting DMO or CSMO in patients with DR who were referred to eye clinics. Diabetic macular oedema and CSMO were diagnosed by means of fundus biomicroscopy by ophthalmologists or stereophotography by ophthalmologists or other trained personnel. </p> </section> <section id="CD008081-sec-0005"> <h3 class="title" id="CD008081-sec-0005">Data collection and analysis</h3> <p>Three authors independently extracted data on study characteristics and measures of accuracy. We assessed data using random‐effects hierarchical sROC meta‐analysis models. </p> </section> <section id="CD008081-sec-0006"> <h3 class="title" id="CD008081-sec-0006">Main results</h3> <p>We included 10 studies (830 participants, 1387 eyes), published between 1998 and 2012. Prevalence of CSMO was 19% to 65% (median 50%) in nine studies with CSMO as the target condition. Study quality was often unclear or at high risk of bias for QUADAS 2 items, specifically regarding study population selection and the exclusion of participants with poor quality images. Applicablity was unclear in all studies since professionals referring patients and results of prior testing were not reported. There was a specific 'unit of analysis' issue because both eyes of the majority of participants were included in the analyses as if they were independent. </p> <p>In nine studies providing data on CSMO (759 participants, 1303 eyes), pooled sensitivity was 0.78 (95% confidence interval (CI) 0.72 to 0.83) and specificity was 0.86 (95% CI 0.76 to 0.93). The median central retinal thickness cut‐off we selected for data extraction was 250 µm (range 230 µm to 300 µm). Central CSMO was the target condition in all but two studies and thus our results cannot be applied to non‐central CSMO. </p> <p>Data from three studies reporting accuracy for detection of DMO (180 participants, 343 eyes) were not pooled. Sensitivities and specificities were about 0.80 in two studies and were both 1.00 in the third study. </p> <p>Since this review was conceived, the role of OCT has changed and has become a key ingredient of decision‐making at all levels of ophthalmic care in this field. Moreover, disagreements between OCT and fundus examination are informative, especially false positives which are referred to as subclinical DMO and are at higher risk of developing clinical CSMO. </p> </section> <section id="CD008081-sec-0007"> <h3 class="title" id="CD008081-sec-0007">Authors' conclusions</h3> <p>Using retinal thickness thresholds lower than 300 µm and ophthalmologist's fundus assessment as reference standard, central retinal thickness measured with OCT was not sufficiently accurate to diagnose the central type of CSMO in patients with DR referred to retina clinics. However, at least OCT false positives are generally cases of subclinical DMO that cannot be detected clinically but still suffer from increased risk of disease progression. Therefore, the increasing availability of OCT devices, together with their precision and the ability to inform on retinal layer structure, now make OCT widely recognised as the new reference standard for assessment of DMO, even in some screening settings. Thus, this review will not be updated further. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008081-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008081-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008081-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008081-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008081-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/ru#CD008081-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008081-abs-0003" lang="en"> <h3>Optical coherence tomography measurement of central retinal thickness to diagnose diabetic macular oedema </h3> <p>Background<br/> Diabetic macular oedema (DMO) is a thickening of the central part of the retina, the macula, that may affect people with diabetic retinopathy (DR). Diabetic retinopathy is a complication of diabetes in which the retina (a layer of tissue at the back of the eye) becomes progressively damaged. Diabetic macular oedema is detected by means of visual examination by an ophthalmologist. The most severe form of DMO ‐ clinically significant macular oedema (CSMO) ‐ is associated with sight loss in the long‐term. This condition is treatable. Laser photocoagulation (where a laser is used to burn off blood vessels) has been used for many years to reduce the risk of visual loss. More recently, antiangiogenic therapy (which prevents fluid leakage from retinal vessels) has been approved to try to improve vision. </p> <p>Review question<br/> Optical coherence tomography (OCT) is based on how light is reflected. It can be used to measure retinal thickness. We originally aimed to assess the accuracy of OCT for diagnosing diabetic macular oedema (DMO), as well as to investigate differences in diagnostic performance. However, the role of OCT is expanding so in the update of this review we also aimed to assess whether OCT might be considered the new standard for diagnosing DMO. </p> <p>Search date<br/> This review is updated as of June 2013. </p> <p>Study characteristics<br/> Our review included 10 studies (830 participants, 1387 eyes) published between 1998 and 2012. Nine of these studies investigated the ability of OCT to diagnose CSMO. </p> <p>Study funding sources<br/> There were no overt declarations of potential conflicts of interest in terms of the manufacturer of the OCT device being involved in funding the research. </p> <p>Key results<br/> We found that OCT retinal thickness measurement is not sufficiently accurate to detect CSMO, involving the centre of the macula, using clinical fundus examination as the reference standard. Of 10 patients with diabetic retinopathy, 5 of whom have CSMO, 1 of 5 with no CSMO would be wrongly diagnosed as having CSMO, and about 1 of 5 with CSMO would be missed. </p> <p>However, researchers have found that disagreements between OCT and clinical examination occur because OCT can detect early, subclinical retinal thickening in people without CSMO and more advanced retinopathy. They suggested that such cases of subclinical macular oedema are followed more closely, since they are at increased risk of progression to CSMO. Furthermore, OCT is an essential tool to manage antiangiogenic therapy in patients with DMO and is believed by many to be a new reference standard for its diagnosis. </p> <p>Quality of the evidence<br/> Study quality was often unclear because of incomplete reporting or because it was at risk of bias. Specifically, this concerned how patients were selected in the study, who referred them and how, and exclusion of those for whom poor quality images were obtained. Furthermore, many studies included both patient's eyes, which is a problem in data analyses. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008081-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008081-sec-0079"></div> <h3 class="title" id="CD008081-sec-0080">Implications for practice</h3> <section id="CD008081-sec-0080"> <p>There is substantial disagreement between OCT central retinal thickness, used at cut‐offs between 230 µm and 300 µm, and fundus biomicroscopy carried out by an ophthalmologist to diagnose CSMO. According to some studies, the characteristics of cases of disagreement may be different and often correspond to milder macular oedema in false positive cases. The identification if such subclinical DMO cases is still useful, as found by <a href="./references#CD008081-bbs2-0039" title="BrowningDJ , FraserCM , ClarkS . The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology2008;115(3):533–9. ">Browning 2008b</a> and others, suggesting that these patients should be followed more carefully by means of clinical examination. The clinical profile of OCT false negatives is unclear, given the studies we used and the literature we searched while preparing and updating this review. </p> <p>Although fundus biomicroscopy is still the current recommendation for routine diagnosis of DMO (<a href="./references#CD008081-bbs2-0029" title="American Academy of Ophthalmology Preferred Practice Patterns Committee. Retina Panel. Preferred Practice Patterns: Diabetic Retinopathy. San Francisco, CA: American Academy of Opthalmology2012. ">AAO PPP 2012</a>), OCT is increasingly used (<a href="./references#CD008081-bbs2-0086" title="SchneiderEW , MruthyunjayaP , TalwarN , Harris NwanyanwuK , NanB , SteinJD . Reduced fluorescein angiography and fundus photography use in the management of neovascular macular degeneration and macular edema over the past decade. Investigative Ophthalmology and Visual Science2014;55(1):542‐9. ">Schneider 2013</a>) and many find it the new reference standard (<a href="./references#CD008081-bbs2-0076" title="OlsonJ , SharpP , GoatmanK , PrescottG , ScotlandG , FlemingA , et al. Improving the economic value of photographic screening for optical coherence tomography‐detectable macular oedema: a prospective, multicentre, UK study. Health Technology Assessment2013;17(51):1‐142. ">Olson 2013</a>; <a href="./references#CD008081-bbs2-0077" title="Medical Advisory Secretariat. Optical coherence tomography for age‐related macular degeneration and diabetic macular edema: an evidence‐based analysis. Ontario Health Technology Assessment Series2009; Vol. 9, issue 13:1‐22. ">Ontario HTA 2009</a>). Thus, no further update of this review will be performed. </p> </section> <h3 class="title" id="CD008081-sec-0081">Implications for research</h3> <section id="CD008081-sec-0081"> <p>Diagnostic accuracy no longer seems to be a useful framework to investigate the use of OCT for diagnosing DMO, given its dominant role in modern practice (<a href="./references#CD008081-bbs2-0076" title="OlsonJ , SharpP , GoatmanK , PrescottG , ScotlandG , FlemingA , et al. Improving the economic value of photographic screening for optical coherence tomography‐detectable macular oedema: a prospective, multicentre, UK study. Health Technology Assessment2013;17(51):1‐142. ">Olson 2013</a>; <a href="./references#CD008081-bbs2-0077" title="Medical Advisory Secretariat. Optical coherence tomography for age‐related macular degeneration and diabetic macular edema: an evidence‐based analysis. Ontario Health Technology Assessment Series2009; Vol. 9, issue 13:1‐22. ">Ontario HTA 2009</a>). The clinical characteristics and outcome of disagreements between OCT and clinical assessment of the macula to detect CSMO would be usefully reported, especially documenting false negative cases. </p> <p>Our review also shows that the unit of analysis issue is a common analytic issue in diagnostic research on macular oedema in patients with DR. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008081-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008081-sec-0022"></div> <div class="table" id="CD008081-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Optical coherence tomography (OCT) for diagnosing clinically significant diabetic macular oedema</span></div> <tbody> <tr class="table-header separated"> <td align="" class="table-header" colspan="3" rowspan="1" valign=""> <p><b> Optical coherence tomography for detection of macular oedema in patients with diabetic retinopathy</b> </p> <p><b>The presentation of the following results assumes that fundus photography or biomicroscopy are valid reference standards for diagnosing diabetic macular oedema (DMO). Readers should be aware of the fact that additional information offered by OCT regarding retinal thickness with respect to the reference standard is useful, specifically for false positives or subclinical DMO, a condition that was found to increase the risk of developing clinically significant macular oedema (CSMO).</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="3" rowspan="1" valign=""> <p><b> Patients or population: patients affected by diabetic retinopathy. Setting: referral eye clinics<br/> IndexTest: optical coherence tomography.<sup>1</sup> Reference Test: stereoscopic fundus photography or contact lens or non‐contact lens biomicroscopy of the fundus. Threshold: proven or probable CSMO based on ETDRS definition</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Test result</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of results</b> <br/> <b>per 1000 patients tested</b> (95% CI) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality</b> <br/> <b>of the evidence</b> <br/> <b>(GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="3" rowspan="1" valign=""> <p><b> Median prevalence 500 per 1000, which is typically seen in patients with diabetes of 15 to 20 years duration since diagnosis, older patients, and patients with additional risk factors.</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>All studies (697 participants, 1242 eyes, 9 studies)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b> 0.81 (0.74 to 0.87)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True positives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>403 per 1000</b> (371 to 428 per 1000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p>Low<sup>2, 3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False negatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>98 per 1000</b> (72 to 129 per 1000) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Specificity (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b> 0.85 (0.75 to 0.91)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True negatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>424 per 1000</b> (374 to 456 per 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False positives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>77 per 1000</b> (44 to 126 per 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Footnotes:</b> </p> <p><sup>1</sup><b>Note:</b> Index Test was OCT 2000 in 2 studies, Stratus in 5 studies, and Cirrus OCT in 2 studies using cut‐off retinal thickness 230 μm to 300 μm. </p> <p><sup>2</sup><b>Risk of bias (‐1):</b> patient selection and missing data were of concern in most studies. </p> <p><sup>3</sup><b>Imprecision (‐1)</b>: unit of analysis issues (eyes v. individuals) may bias precision. </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="3" rowspan="1" valign=""> <p><b> Low prevalence 100 per 1000, which is typically seen in patients with diabetes of 5 to 10 years duration since diagnosis and no other risk factors.</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Estimates at prevalence less than 50% (19% to 40%: 4 studies)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b> 0.74 (0.68 to 0.86)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True positives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>74 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p>Very low<sup>2, 3, 4</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False negatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>26 per 1000</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Specificity (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b> 0.92 (0.87 to 0.97)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True negatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>828 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False positives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>72 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>CI:</b> Confidence interval, <b>OCT</b> : Optical coherence tomography, <b>ETDRS</b>: Early Treatment Diabetic Retinopathy Study </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><sup>1</sup><b>Note:</b> Index Test was OCT 2000 in 2 studies, Stratus in 5 studies, and Cirrus OCT in 2 studies using cut‐off retinal thickness 230 μm to 300 μm. </p> <p><sup>2</sup><b>Risk of bias (‐1):</b> patient selection and missing data were of concern in most studies. </p> <p><sup>3</sup><b>Indirectness (‐1)</b>: low‐prevalence subgroup estimate is far from values expected in primary care. </p> <p><sup>4</sup><b>Imprecision (‐1)</b>: unit of analysis issues (eyes v. individuals) may bias precision. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008081-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008081-sec-0023"></div> <section id="CD008081-sec-0024"> <h3 class="title" id="CD008081-sec-0024">Target condition being diagnosed</h3> <p>Diabetes mellitus results in considerable morbidity and mortality, affecting about 180 million people worldwide (<a href="./references#CD008081-bbs2-0094" title="World Health Organization. The World Health Report 2002. www.who.int/whr/en. ">WHO 2002</a>). The total number of people with diabetes is expected to rise to an estimated 300 million cases by the year 2025, with the most significant increases in developing countries. The increase is thought to be the result of population growth, ageing, obesity and sedentary lifestyle (<a href="./references#CD008081-bbs2-0063" title="KingH , AubertRE , HermanWH . Global burden of diabetes, 1995‐2025: prevalence, numerical estimates, and projections. Diabetes Care1998;21(9):1414‐31. ">King 1998</a>). </p> <p>Approximately 25% of people with diabetes have at least some form of diabetic retinopathy (DR) and the incidence increases with the duration of the diabetes. At 10 years the prevalence of retinopathy in diabetic patients is 7%, after 25 years it is more than 90% (<a href="./references#CD008081-bbs2-0031" title="AielloLP , GardnerTW , KingGL , BlankenshipG , CavalleranoJD , Ferris IIIFL . Diabetic retinopathy. Diabetes Care1998;21(1):143‐56. ">Aiello 1998</a>). In developed countries, <a href="./references#CD008081-bbs2-0074" title="National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease. Diabetes in America. 2nd Edition. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, 1995. ">NIH 1995</a> found that diabetic eye disease represents the leading cause of blindness in adults under 75 years of age. </p> <p>There are two main complications of DR causing visual loss (<a href="./references#CD008081-bbs2-0032" title="AielloML . Perspectives of diabetic retinopathy. American Journal of Ophthalmology2003;136(1):122‐35. ">Aiello 2003</a>; <a href="./references#CD008081-bbs2-0062" title="KiireCA , PortaM , ChongV . Medical management for the prevention and treatment of diabetic macular edema. Survey of Ophthalmology2013;58(5):459‐65. ">Kiire 2013</a>). These are proliferative retinopathy and diabetic macular oedema (DMO). Proliferative DR is the occurrence of retinal neovascularisation caused by retinal ischaemia and may lead to severe visual loss due to intraocular haemorrhage and retinal detachment. Diabetic macular oedema is a thickening of the central portion of the retina, called the macula. It is often associated with deposits of lipoproteins or hard exudates and may lead to gradual loss of central vision due to deterioration of the retinal cells. Clinically significant macular oedema (CSMO) is the most severe form of DMO. Diabetic macular oedema increases with the duration of diabetes and its prevalence is 5% within the first five years after diagnosis and 15% at 15 years (<a href="./references#CD008081-bbs2-0031" title="AielloLP , GardnerTW , KingGL , BlankenshipG , CavalleranoJD , Ferris IIIFL . Diabetic retinopathy. Diabetes Care1998;21(1):143‐56. ">Aiello 1998</a>). A review of studies found a prevalence of CSMO in people with diabetes ranging from 2% to almost 10% (<a href="./references#CD008081-bbs2-0095" title="WilliamsR , AireyM , BaxterH , ForresterJ , Kennedy‐MartinT , GirachA . Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye2004;18(10):963–83. ">Williams 2004</a>). </p> <p>According to the Diabetic Retinopathy Study (DRS) Group, the risk of severe visual loss at two years was 3.2% for eyes with non‐proliferative DR (<a href="./references#CD008081-bbs2-0050" title="The Diabetic Retinopathy Study Research Group. Indications for photocoagulation treatment of diabetic retinopathy. Diabetic Retinopathy Study Report Number 14. International Ophthalmology Clinics1987;27(4):239‐53. ">DRS 1987</a>). The presence of CSMO increases the risk of moderate visual loss to approximately 30% to 50% depending on the level of baseline visual acuity. It is an indication for grid or focal laser treatment (<a href="./references#CD008081-bbs2-0060" title="JavittJC , CannerJK , SommerA . Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology1989;96(2):255‐64. ">Javitt 1989</a>). </p> <p>Stereoscopic fundus photography was used to diagnose macular oedema in the Early Treatment Diabetic Retinopathy Study (<a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a>) and has been used as a standard method in research. In clinical practice, ophthalmologists routinely use contact or non‐contact stereoscopic fundus biomicroscopy to diagnose macular oedema. In primary care, other healthcare professionals may use direct ophthalmoscopy or non‐stereoscopic fundus photography to detect DR, but these methods do not allow the examiner to perceive retinal thickening as a primary sign of macular oedema. Only hard exudates or indirect signs, such as haemorrhages or microaneurysms in the macula, can be identified. Telemedicine is increasingly used for photographic screening and monitoring DR in diabetic patients (<a href="./references#CD008081-bbs2-0032" title="AielloML . Perspectives of diabetic retinopathy. American Journal of Ophthalmology2003;136(1):122‐35. ">Aiello 2003</a>). </p> <p>People with DR are referred to ophthalmologists for confirmatory diagnosis and treatment of visually impairing complications such as proliferative retinopathy or CSMO. Nearly three decades ago, the ETDRS study showed that grid or focal laser photocoagulation reduces the risk of moderate visual loss by 50% in patients with CSMO (<a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a>). </p> <p>Recent studies found that intravitreal steroids (<a href="./references#CD008081-bbs2-0057" title="GroverD , LiTJ , ChongCCW . Intravitreal steroids for macular edema in diabetes. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD005656.pub2] ">Grover 2008</a>) or, in particular, antiangiogenic therapy with anti‐vascular endothelial growth factor (anti‐VEFG) properties, also injected intravitreally, may improve vision in patients affected by macular oedema due to DR (<a href="./references#CD008081-bbs2-0042" title="CunninghamETJr , AdamisAP , AltaweelM , AielloLP , BresslerNM , D'AmicoDJ , et al. Macugen Diabetic Retinopathy Study Group. A phase II randomized double‐masked trial of pegaptanib, an anti‐vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology2005;112(10):1747‐57. ">Cunningham 2005</a>; <a href="./references#CD008081-bbs2-0044" title="ScottIU , EdwardsAR , BeckRW , BresslerNM , ChanCK , ElmanMJ , et al. Diabetic Retinopathy Clinical Research Network. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology2007;114(10):1860‐7. ">DRCR Network 2007a</a>; <a href="./references#CD008081-bbs2-0048" title="ElmanMJ , AielloLP , BeckRW , BresslerNM , BresslerSB , EdwardsAR , et al. Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology2010;117(6):1064‐77. ">DRCR Network 2010</a>; <a href="./references#CD008081-bbs2-0082" title="MassinP , BandelloF , GarwegJG , HansenLL , HardingSP , LarsenM , et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12‐month, randomized, controlled, double‐masked, multicenter phase II study. Diabetes Care2010;33(11):2399‐405. ">RESOLVE 2010</a>; <a href="./references#CD008081-bbs2-0091" title="VirgiliG , ParravanoM , MenchiniF , EvansJR . Anti‐vascular endothelial growth factor for diabetic macular oedema. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD007419.pub4] ">Virgili 2014</a>). </p> </section> <section id="CD008081-sec-0025"> <h3 class="title" id="CD008081-sec-0025">Index test(s)</h3> <p>Optical coherence tomography (OCT) produces cross‐sectional images of optical reflectivity in the retina, analogous to an ultrasound B‐scan but with higher resolution (<a href="./references#CD008081-bbs2-0006" title="HeeMR , PuliafitoCA , DukerJS , ReichelE , CokerJG , WilkinsJR , et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology1998;105(2):360‐70. ">Hee 1998</a>). Measurements of retinal thickness may be obtained directly from the tomograms either by manually measuring the distance between the inner and outer retinal boundaries or by using computer image processing techniques. Optical coherence tomography is increasingly used for detecting macular oedema in people with DR because OCT is an objective and reliable tool (<a href="./references#CD008081-bbs2-0045" title="KrzystolikMG , StrauberSF , AielloLP , BeckRW , BergerBB , BresslerNM , et al. Diabetic Retinopathy Clinical Research Network. Reproducibility of macular thickness and volume using zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology2007;114(8):1520‐5. ">DRCR Network 2007b</a>). Furthermore, OCT allows a quantitative follow‐up of the effects of treatment and has become a tool for routine management of macular oedema by ophthalmologists (<a href="./references#CD008081-bbs2-0085" title="SchimelAM , FisherYL , FlynnHWJr . Optical coherence tomography in the diagnosis and management of diabetic macular edema: time‐domain versus spectral‐domain. Ophthalmic Surgery, Lasers and Imaging2011;42(Suppl):S41‐55. ">Schimel 2011</a>). </p> <p>Other macular changes are of interest to researchers and clinicians using OCT, such as macular hyporeflective cavities or cysts due to fluid accumulation, subretinal fluid, or a thickened adherent hyaloid suggestive of vitreous traction (<a href="./references#CD008081-bbs2-0041" title="ChanA , DukerJS . A standardized method for reporting changes in macular thickening using optical coherence tomography. Archives of Ophthalmology2005;123(7):939‐43. ">Chan 2005</a>). Newer spectral domain OCT devices have higher resolution than previously and may show further abnormalities of the retinal layers, including those of the photoreceptor layer (<a href="./references#CD008081-bbs2-0033" title="AlasilT , KeanePA , UpdikeJF , DustinL , OuyangY , WalshAC , et al. Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology2010;117(12):2379‐86. ">Alasil 2010</a>). However, because the construct underlying DMO is that of thickening, we will only consider thickness‐related measures in this review. </p> <p>This review is a diagnostic test accuracy review aimed at investigating the performance of OCT for detecting an anatomic target condition (DMO and particularly its severe form, CSMO). The target condition was shown several years ago to be relevant to affected people in terms of prognosis and an indication for treatment (<a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a>). However, the increasing availability of OCT devices, coupled with their precision and the ability to inform on retinal layer structure, make OCT increasingly recognised as the new reference standard for assessment of DMO, even in screening settings (<a href="./references#CD008081-bbs2-0076" title="OlsonJ , SharpP , GoatmanK , PrescottG , ScotlandG , FlemingA , et al. Improving the economic value of photographic screening for optical coherence tomography‐detectable macular oedema: a prospective, multicentre, UK study. Health Technology Assessment2013;17(51):1‐142. ">Olson 2013</a>; <a href="./references#CD008081-bbs2-0077" title="Medical Advisory Secretariat. Optical coherence tomography for age‐related macular degeneration and diabetic macular edema: an evidence‐based analysis. Ontario Health Technology Assessment Series2009; Vol. 9, issue 13:1‐22. ">Ontario HTA 2009</a>). Thus, this review will not be updated further. </p> </section> <section id="CD008081-sec-0026"> <h3 class="title" id="CD008081-sec-0026">Clinical pathway</h3> <p>In the updated version of this review, we acknowledge that the clinical pathway of patients with DMO is unclear and probably dependent on the country and setting. Thus, the applicability of the results of the review will depend on patient selection in included studies, such as inclusion criteria and results of prior testing. Different levels of care may include DR screening programmes of diabetic patients (<a href="./references#CD008081-bbs2-0059" title="HautalaN , AikkilaR , KorpelainenJ , KeskitaloA , KurikkaA , FalckA , et al. Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment. Acta Ophthalmologica2014;92(6):582‐7. ">Hautala 2013</a>; <a href="./references#CD008081-bbs2-0079" title="PetoT , TadrosC . Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom. Current Diabetes Reports2012;12(4):338‐45. ">Peto 2012</a>), DR detection by optometrists and other non‐medical eye care professionals in public or private eye care settings, and diagnosis and treatment in secondary or tertiary care by ophthalmologists or retinal specialists. </p> <p>Diabetic retinopathy screening by means of non‐mydriatic fundus photography and telemedicine is now established in many countries (<a href="./references#CD008081-bbs2-0034" title="AndoneguiJ , ZurutuzaA , deArcelusMP , SerranoL , EguzkizaA , AuzmendiM , et al. Diabetic retinopathy screening with non‐mydriatic retinography by general practitioners: 2‐year results. Primary Care Diabetes2012;6(3):201‐5. ">Andonegui 2012</a>; <a href="./references#CD008081-bbs2-0071" title="MansbergerSL , GleitsmannK , GardinerS , ShepplerC , DemirelS , WootenK , et al. Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: a randomized controlled trial. Telemedicine Journal and E‐Health2013;19(12):942‐8. ">Mansberger 2013</a>; <a href="./references#CD008081-bbs2-0078" title="PengJ , ZouH , WangW , FuJ , ShenB , BaiX , et al. Implementation and first‐year screening results of an ocular telehealth system for diabetic retinopathy in China. BMC Health Services Research2011;11:250. ">Peng 2011</a>; <a href="./references#CD008081-bbs2-0079" title="PetoT , TadrosC . Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom. Current Diabetes Reports2012;12(4):338‐45. ">Peto 2012</a>; <a href="./references#CD008081-bbs2-0089" title="VaziriK , MoshfeghiDM , MoshfeghiAA . Feasibility of telemedicine in detecting diabetic retinopathy and age‐related macular degeneration. Seminars in Ophthalmology 2013 Oct 30 [Epub ahead of print]. ">Vaziri 2013</a>). The increasing availability and decreasing cost of OCT devices is making OCT attractive as a means of improving DMO detection within photographic telemedicine programmes, especially for reducing false positive referrals compared to fundus imaging alone (<a href="./references#CD008081-bbs2-0030" title="AdhiM , DukerJS . Optical coherence tomography‐‐current and future applications. Current Opinion in Ophthalmology2013;24(3):213‐21. ">Adhi 2013</a>; <a href="./references#CD008081-bbs2-0070" title="MackenzieS , SchmermerC , CharnleyA , SimD , TahV , DumskyjM , et al. SDOCT imaging to identify macular pathology in patients diagnosed with diabetic maculopathy by a digital photographic retinal screening programme. PloS One2011;6(5):e14811. ">Mackenzie 2011</a>; <a href="./references#CD008081-bbs2-0076" title="OlsonJ , SharpP , GoatmanK , PrescottG , ScotlandG , FlemingA , et al. Improving the economic value of photographic screening for optical coherence tomography‐detectable macular oedema: a prospective, multicentre, UK study. Health Technology Assessment2013;17(51):1‐142. ">Olson 2013</a>). </p> <p>In many European and North‐American countries, optometrists or other professionals may screen referred or self‐referred patients for some ocular diseases, such as diabetic retinopathy or glaucoma, and then refer some patients to ophthalmologists based on tests such as fundus examination or photography and ocular pressure measurement. Other countries, such as Italy, rely on ophthalmologists for primary care needs. There is an interest in using OCT devices at this level of care (<a href="./references#CD008081-bbs2-0087" title="SheltonRL , JungW , SayeghSI , McCormickDT , KimJ , BoppartSA . Optical coherence tomography for advanced screening in the primary care office. Journal of Biophotonics2014;7(7):525‐33. ">Shelton 2013</a>). </p> <p>Patients referred from primary care to ophthalmologists for suspect DR are first assessed by means of fundus biomicroscopy. Therefore, OCT and fluorescein angiography are used if DMO or proliferative retinopathy are found. In countries such as the UK, the choice between antiangiogenic therapy and laser also depends on OCT thickness, following the decision of the National Institute for Clinical Excellence (<a href="./references#CD008081-bbs2-0073" title="National Institute for Health and Clinical Excellence. Ranibizumab for the treatment of diabetic macular oedema Issued: NICE technology appraisal guidance 237. www.nice.org.uk/nicemedia/live/13125/55324/55324.pdf (accessed 31 October 2013). ">NICE 2011</a>) of reimbursing ranibizumab only if central retinal thickness is 400 µm or more, based on a subgroup analysis of the <a href="./references#CD008081-bbs2-0083" title="MitchellP , BandelloF , Schmidt‐ErfurthU , LangGE , MassinP , SchlingemannRO , et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology2011;118(4):615–62. ">RESTORE 2011</a> study. </p> <p>The classification of DMO to decide on treatment options is not standardised and may ultimately depend on the ophthalmologist's assessment of several clinical components. These may include visual acuity and the chronicity of the condition, the existence of a thickened and adherent hyaloid, an epiretinal membrane and vitreous traction to the retina, the degree of ischaemia and the presumed "vasogenic" origin which was believed to benefit more with laser photocoagulation compared to the diffuse type (<a href="./references#CD008081-bbs2-0035" title="BandelloF , Battaglia ParodiM , TremoladaG , LattanzioR , DeBenedettoU , IaconoP . Steroids as part of combination treatment: the future for the management of macular edema?. Ophthalmologica2010;224(Suppl 1):41‐5. ">Bandello 2010</a>). Optical coherence tomography is able to display some of these features, particularly the vitreous‐retina interface, as well as any subretinal fluid, the integrity of the photoreceptor layers, and patterns of uncertain interpretation such as hyperreflective foci (<a href="./references#CD008081-bbs2-0055" title="FrammeC , SchweizerP , ImeschM , WolfS , Wolf‐SchnurrbuschU . Behavior of SD‐OCT‐detected hyperreflective foci in the retina of anti‐VEGF‐treated patients with diabetic macular edema. Investigative Ophthalmology and Visual Science2012;53(9):5814‐8. ">Framme 2012</a>; <a href="./references#CD008081-bbs2-0098" title="YohannanJ , BittencourtM , SepahYJ , HatefE , SophieR , MoradiA , et al. Association of retinal sensitivity to integrity of photoreceptor inner/outer segment junction in patients with diabetic macular edema. Ophthalmology2013;120(6):1254‐61. ">Yohannan 2013</a>). The attempt to classify DMO in focal or diffuse patterns in clinical trials, based on the amount of leakage from microaneurysms, failed to show an impact on prognosis and the response to angiogenic therapy (<a href="./references#CD008081-bbs2-0083" title="MitchellP , BandelloF , Schmidt‐ErfurthU , LangGE , MassinP , SchlingemannRO , et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology2011;118(4):615–62. ">RESTORE 2011</a>). In addition, such classification was found to have been used inconsistently (<a href="./references#CD008081-bbs2-0040" title="BrowningDJ , AltaweelMM , BresslerNM , BresslerSB , ScottIU , Diabetic Retinopathy Clinical Research Network. Diabetic macular edema: what is focal and what is diffuse?. American Journal of Ophthalmology2008;146(5):649‐55. ">Browning 2008c</a>). Diagnostic questions related to these features are complex and cannot be investigated in the diagnostic accuracy framework, according to our judgement. </p> <section id="CD008081-sec-0027"> <h4 class="title">Prior test(s)</h4> <p>In the accuracy framework in which OCT is used in primary care to detect DMO and then verified by an ophthalmologist with fundus biomicroscopic examination, prior testing should be fundus examination or photography interpreted by optometrists, trained nurses, general practitioners, or automated software. </p> </section> <section id="CD008081-sec-0028"> <h4 class="title">Role of index test(s)</h4> <p>Given the ill‐defined nature and the complexity of clinical pathways, plus the increasing importance of OCT, this updated review differs from the original version. It reinforces the statement that DMO detection primarily by means of OCT, followed by referral to an ophthalmologist using fundus biomicroscopy as verification, is an accuracy question that can be relevant only in specific settings in which this pathway is followed; perhaps in some primary eye‐care settings (<a href="./references#CD008081-bbs2-0087" title="SheltonRL , JungW , SayeghSI , McCormickDT , KimJ , BoppartSA . Optical coherence tomography for advanced screening in the primary care office. Journal of Biophotonics2014;7(7):525‐33. ">Shelton 2013</a>). </p> <p>When ophthalmologists have to decide on treatment and prognosis of DMO, OCT has a dominant role, and in this revised review we agree that fundus examination cannot be used as a reference standard in clinical contexts (<a href="./references#CD008081-bbs2-0077" title="Medical Advisory Secretariat. Optical coherence tomography for age‐related macular degeneration and diabetic macular edema: an evidence‐based analysis. Ontario Health Technology Assessment Series2009; Vol. 9, issue 13:1‐22. ">Ontario HTA 2009</a>). At this step of care, research has focused on the patterns of agreement between OCT and fundus examination (<a href="./references#CD008081-bbs2-0004" title="DavisMD , BresslerSB , AielloLP , BresslerNM , BrowningDJ , FlaxelCJ , et al. Diabetic Retinopathy Clinical Research Network Study Group. Comparison of time‐domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Investigative Ophthalmology and Visual Science2008;49(5):1745‐52. ">Davis 2008</a>), and particularly on the clinical characteristics of subclinical DMO, which is detected by OCT as a retinal thickness in the 225 µm to 300 µm range in the absence of biomicroscopic detection of CSMO (<a href="./references#CD008081-bbs2-0036" title="BhavsarKV , SubramanianML . Risk factors for progression of subclinical diabetic macular oedema. British Journal of Ophthalmology2011;95(5):671‐4. ">Bhavsar 2011</a>; <a href="./references#CD008081-bbs2-0038" title="BrowningDJ , FraserCM . The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. American Journal of Ophthalmology2008;145(1):149‐54. ">Browning 2008a</a>; <a href="./references#CD008081-bbs2-0039" title="BrowningDJ , FraserCM , ClarkS . The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology2008;115(3):533–9. ">Browning 2008b</a>; <a href="./references#CD008081-bbs2-0049" title="BresslerNM , MillerKM , BeckRW , BresslerSB , GlassmanAR , KitchensJW , et al. Diabetic Retinopathy Clinical Research Network. Observational study of subclinical diabetic macular edema. Eye2012;26(6):833‐40. ">DRCR Network 2012</a>; <a href="./references#CD008081-bbs2-0080" title="PiresI , SantosAR , NunesS , LoboC , Cunha‐VazJ . Subclinical macular edema as a predictor of progression to clinically significant macular edema in type 2 diabetes. Ophthalmologica2013;230(4):201‐6. ">Pires 2013</a>). In fact, landmark <a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a> and <a href="./references#CD008081-bbs2-0053" title="Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Archives of Ophthalmology1995;113(9):1144‐55. ">ETDRS 1995</a> studies on photocoagulation showed that DMO less than CSMO may have a good prognosis and less benefit, compared to those with CSMO, with photocoagulation compared to observation. Recently, OCT has offered additional clues on the relationship between central retinal thickness and treatment response. <a href="./references#CD008081-bbs2-0083" title="MitchellP , BandelloF , Schmidt‐ErfurthU , LangGE , MassinP , SchlingemannRO , et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology2011;118(4):615–62. ">RESTORE 2011</a> showed that the gain in vision with ranibizumab treatment compared to photocoagulation is about the same as photocoagulation when OCT retinal thickness is less than 300 µm. In 2011, the UK National Institute for Clinical Excellence (NICE) decided to reimburse ranibizumab treatment only in cases where OCT thickness is less than 400 µm (<a href="./references#CD008081-bbs2-0073" title="National Institute for Health and Clinical Excellence. Ranibizumab for the treatment of diabetic macular oedema Issued: NICE technology appraisal guidance 237. www.nice.org.uk/nicemedia/live/13125/55324/55324.pdf (accessed 31 October 2013). ">NICE 2011</a>). Apparently contradicting this finding, based on further subgroup analyses based on <a href="./references#CD008081-bbs2-0083" title="MitchellP , BandelloF , Schmidt‐ErfurthU , LangGE , MassinP , SchlingemannRO , et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology2011;118(4):615–62. ">RESTORE 2011</a> data, <a href="./references#CD008081-bbs2-0072" title="MitchellP , BresslerN , TolleyK , GallagherM , PetrilloJ , FerreiraA , et al. Patient‐reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial. JAMA Ophthalmology2013;131(10):1339‐47. ">Mitchell 2013</a> has shown that quality of life gain, measured with the National Eye Institute Visual Functioning Questionnaire, is greater with ranibizumab than laser when thickness is lower than 400 µm and vision is better than about 68 letter, or about 20/50. These results are difficult to interpret since the subgroups are small and because vision‐related quality of life is conventionally presumed to be dependent on the eye with better vision, although visual loss in diabetic patients is not only more symmetric but also milder than in age‐related macular degeneration. </p> </section> <section id="CD008081-sec-0029"> <h4 class="title">Alternative test(s)</h4> <p>Despite the fact that retinal thickness measurements with OCT have been compared to those obtained using the Retinal Thickness Analyzer in at least one study, such a comparison is no longer of interest given the dominant use of OCT devices (<a href="./references#CD008081-bbs2-0005" title="GoebelW , FrankeR . Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina2006;26(1):49‐57. ">Goebel 2006</a>). Therefore, OCT is the only index test evaluated in this review. </p> </section> </section> <section id="CD008081-sec-0030"> <h3 class="title" id="CD008081-sec-0030">Rationale</h3> <p>When this review was first published, it was important because OCT was increasingly used at all levels of care to confirm the presence or absence of DMO and to monitor treatment outcomes. As stated before, at present the results of this review may be applicable to inform decisions only in specific contexts. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008081-sec-0031" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008081-sec-0031"></div> <p>To determine the diagnostic accuracy of OCT for detecting DMO and CSMO, defined according to <a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a>, in patients referred to ophthalmologists after DR is detected. In the update of this review we also aimed to assess whether OCT might be considered the new reference standard for detecting DMO. </p> <section id="CD008081-sec-0032"> <h3 class="title" id="CD008081-sec-0032">Secondary objectives</h3> <section id="CD008081-sec-0033"> <h4 class="title">1) Heterogeneity investigation</h4> <p>To determine which retinal thickness cut‐off or which OCT algorithm yields the best diagnostic performance. In fact, clinicians may use different thresholds of retinal thickness to define DMO and CSMO. Furthermore, thickness can be calculated using different algorithms (such as, previously, central point thickness or, currently, central subfield thickness, which were found to be highly correlated in <a href="./references#CD008081-bbs2-0047" title="BrowningDJ , GlassmanAR , AielloLP , BresslerNM , BresslerSB , DanisRP , et al. Diabetic Retinopathy Clinical Research Network. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology2008;115(8):1366‐71. ">DRCR Network 2008</a>) or other algorithms that try to detect paracentral retinal thickening (<a href="./references#CD008081-bbs2-0009" title="SaddaSR , TanO , WalshAC , SchumanJS , VarmaR , HuangD . Automated detection of clinically significant macular edema by grid scanning optical coherence tomography. Ophthalmology2006;113(7):1187‐96. ">Sadda 2006</a>). </p> <p>Based on a previous systematic review on this topic, conducted by some of the authors (<a href="./references#CD008081-bbs2-0090" title="VirgiliG , MenchiniF , DimastrogiovanniAF , RapizziE , MenchiniU , BandelloF , et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Investigative Ophthalmology and Visual Science2007;48(11):4963‐73. ">Virgili 2007</a>), we initially planned to investigate the following sources of clinical heterogeneity. </p> <p><b>A. Heterogeneity related to retinal thickness cut‐off</b> </p> <p>We originally planned to explore which cut‐off value of central retinal thickness represents the best trade‐off of sensitivity and specificity for clinical use. We selected only two pre‐planned cut‐offs because data driven cut‐off selection has been found to lead to optimistic estimates of sensitivity and specificity, especially in small studies (<a href="./references#CD008081-bbs2-0065" title="LeeflangMM , MoonsKG , ReitsmaJB , ZwindermanAH . Bias in sensitivity and specificity caused by data‐driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clinical Chemistry2008;54(4):729‐37. ">Leeflang 2008</a>). Based on the <a href="./references#CD008081-bbs2-0090" title="VirgiliG , MenchiniF , DimastrogiovanniAF , RapizziE , MenchiniU , BandelloF , et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Investigative Ophthalmology and Visual Science2007;48(11):4963‐73. ">Virgili 2007</a> review, we expected to report on a sensitive and a specific threshold, corresponding to values of 250 µm and 300 µm (± 25 µm for both cut‐offs). However, only one study reported both thresholds and we used the available information as explained later in the review. Furthermore, the calibration of different OCT devices was found to vary, making the effect of using a specific threshold inconsistent (<a href="./references#CD008081-bbs2-0096" title="Wolf‐SchnurrbuschUE , CeklicL , BrinkmannCK , IlievME , FreyM , RothenbuehlerSP , et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Investigative Ophthalmology and Visual Science2009;50(7):3432‐7. ">Wolf‐Schnurrbusch 2009</a>). </p> <p><b>B. Heterogeneity related to index test</b> </p> <p> <ol id="CD008081-list-0001"> <li> <p>Which OCT definition of CSMO should be preferred, such as using the central thickness subfield or complex diagnostic algorithms? </p> </li> <li> <p>What is the difference between OCT models of different generations which were found to yield different measurements (<a href="./references#CD008081-bbs2-0054" title="ForooghianF , CukrasC , MeyerleCB , ChewEY , WongWT . Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Investigative Ophthalmology and Visual Science2008;49(10):4290‐6. ">Forooghian 2008</a>; <a href="./references#CD008081-bbs2-0061" title="KiernanDF , HariprasadSM , ChinEK , KiernanCL , RagoJ , MielerWF . Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness. American Journal of Ophthalmology2009;147(2):267‐75. ">Kiernan 2009</a>; <a href="./references#CD008081-bbs2-0096" title="Wolf‐SchnurrbuschUE , CeklicL , BrinkmannCK , IlievME , FreyM , RothenbuehlerSP , et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Investigative Ophthalmology and Visual Science2009;50(7):3432‐7. ">Wolf‐Schnurrbusch 2009</a>)? </p> </li> </ol> </p> <p><b>C. Heterogeneity related to reference standard</b> </p> <p> <ol id="CD008081-list-0002"> <li> <p>What is the impact of the type of reference standard used, i.e. stereophotography, contact or non‐contact lens biomicroscopy? </p> </li> </ol> </p> <p><b>D. Heterogeneity related to characteristics of the study population</b> </p> <p> <ol id="CD008081-list-0003"> <li> <p>What is the performance of OCT in higher versus lower prevalence studies? (Taking into account that we planned to include clinic‐based series, a level of prevalence around 30% was considered a priori.) </p> </li> </ol> </p> <p><b>E. Heterogeneity related to methodological study quality items</b> </p> <p>See <a href="./appendices#CD008081-sec-0085">Appendix 1</a> of the QUADAS 2 checklist (<a href="./references#CD008081-bbs2-0093" title="WhitingPF , RutjesAW , WestwoodME , MallettS , DeeksJJ , ReitsmaJB , et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine2011;155(8):529‐36. ">Whiting 2011</a>) which replaced QUADAS (<a href="./references#CD008081-bbs2-0092" title="WhitingP , RutjesAW , ReitsmaJB , BossuytPM , KleijnenJ . The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology2003;3:25. ">Whiting 2003</a>) in the update of this review. We dichotomised QUADAS 2 items using yes versus other categories and planned to use a Risk of Bias or Applicability as covariate if the smaller subgroup included at least three studies. </p> </section> <section id="CD008081-sec-0034"> <h4 class="title">2) To assess whether OCT might be considered the new reference standard</h4> <p>The updated version of this review included an introductory section on the clinical pathways and the role of the index test, which is now a mandatory item in <a href="./references#CD008081-bbs2-0084" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>. The diagnostic accuracy framework is valid if the clinical reference standard is the best available method for establishing the presence or absence of the target (<a href="./references#CD008081-bbs2-0037" title="BossuytPM , LeeflangMM . Chapter 6: Developing criteria for including studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008. ">Bossuyt 2008</a>) and implies that, in patients with discordant results, the reference standard is true and the index test is wrong. </p> <p>Diagnostic studies can take the "agreement" rather than the "accuracy" perspective to compare OCT and fundus examination, implying that neither test was believed to be more valid than the other. <a href="./references#CD008081-bbs2-0039" title="BrowningDJ , FraserCM , ClarkS . The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology2008;115(3):533–9. ">Browning 2008b</a>; <a href="./references#CD008081-bbs2-0075" title="OckrimZ , YorstonD . Managing diabetic retinopathy. BMJ2010;341:c5400. ">Ockrim 2010</a>; <a href="./references#CD008081-bbs2-0076" title="OlsonJ , SharpP , GoatmanK , PrescottG , ScotlandG , FlemingA , et al. Improving the economic value of photographic screening for optical coherence tomography‐detectable macular oedema: a prospective, multicentre, UK study. Health Technology Assessment2013;17(51):1‐142. ">Olson 2013</a> and <a href="./references#CD008081-bbs2-0077" title="Medical Advisory Secretariat. Optical coherence tomography for age‐related macular degeneration and diabetic macular edema: an evidence‐based analysis. Ontario Health Technology Assessment Series2009; Vol. 9, issue 13:1‐22. ">Ontario HTA 2009</a> believed that OCT is more sensitive than clinical examination or stereoscopic fundus photography for the detection of retinal thickening. <a href="./references#CD008081-bbs2-0068" title="LordSJ , IrwigL , SimesRJ . When is measuring sensitivity and speciﬁcity sufﬁcient to evaluate a diagnostic test, and when do we need randomized trials?. Annals of Internal Medicine2006;144(11):850‐5. ">Lord 2006</a> and <a href="./references#CD008081-bbs2-0069" title="LordSJ , IrwigL , BossuytPM . Using the principles of randomized controlled trial design to guide test evaluation. Medical Decision Making2009;29:E1–E12. ">Lord 2009</a> advised that whenever clinicians use a new diagnostic test because it is more sensitive than an old test, they need to be clear about the assumptions linking this evidence to improved patient outcomes, such as evidence that the new test detects the same spectrum of disease as the old test, or that similar treatment efficacy exists across the spectrum of disease. Although this issue is not an aim of our review, and we did not try to systematically investigate it, it is clearly key in interpreting and using our results and will be discussed based on articles assessed during the preparation of this review, as well as their relevant references. </p> </section> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008081-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008081-sec-0035"></div> <section id="CD008081-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008081-sec-0037"> <h4 class="title">Types of studies</h4> <p>We planned to include all prospective and retrospective consecutive series of patients and case‐control studies that evaluated the accuracy of OCT for diagnosing DMO. As discussed above, we acknowledge that the clinical pathway is unclear and may vary across settings and countries. Therefore, we accepted studies in which a two‐by‐two table was presented which crossed the results of OCT retinal thickness, dichotomised at the approximate thresholds of interest, with ophthalmologists' detection of DMO or CSMO by means of fundus biomicroscopy or photography as defined later. We recorded the settings in which patients were recruited and examined in each study. </p> </section> <section id="CD008081-sec-0038"> <h4 class="title">Participants</h4> <p>Included participants were people referred to ophthalmologists because they had been found to have some level of DR, expectedly by primary care professionals, such as optometrists, diabetologists and general practitioners, or by other ophthalmologists. </p> <p>Prevalence is often an indicator of severity of disease spectrum in a study. If patients with any level of DR were examined, the prevalence of DMO would be expected to be lower than 10% (<a href="./references#CD008081-bbs2-0095" title="WilliamsR , AireyM , BaxterH , ForresterJ , Kennedy‐MartinT , GirachA . Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye2004;18(10):963–83. ">Williams 2004</a>; <a href="./references#CD008081-bbs2-0097" title="YauJW , RogersSL , KawasakiR , LamoureuxEL , KowalskiJW , BekT , et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care2012;35(3):556‐64. ">Yau 2012</a>). However, a relatively high prevalence of DMO was expected, as found in studies included in a previous systematic review (<a href="./references#CD008081-bbs2-0090" title="VirgiliG , MenchiniF , DimastrogiovanniAF , RapizziE , MenchiniU , BandelloF , et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Investigative Ophthalmology and Visual Science2007;48(11):4963‐73. ">Virgili 2007</a>) and conducted in retina practices, suggesting that a diagnosis of more severe DR, or even any DMO, had already been carried out in the study population. </p> </section> <section id="CD008081-sec-0039"> <h4 class="title">Index tests</h4> <p>The index test was OCT, regardless of the generation of development of the instrument (low or high resolution, three‐dimensional or spectral‐domain OCTs). </p> <p>Despite the fact that retinal thickness measurements with OCT have been compared to those obtained with the Retinal Thickness Analyzer in at least one study (<a href="./references#CD008081-bbs2-0005" title="GoebelW , FrankeR . Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina2006;26(1):49‐57. ">Goebel 2006</a>), based on our knowledge we believe that such a comparison is no longer of interest given the dominant use of OCT devices. We are not aware of any other instruments that can be compared to OCT. </p> </section> <section id="CD008081-sec-0040"> <h4 class="title">Target conditions</h4> <p>Our review considered the target conditions as both the general definition of DMO and its most severe type, CSMO. In fact, finding the milder form of DMO still has implications regarding the need for closer follow‐up as well as on visual prognosis (<a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a>). The ETDRS definitions of DMO and CSMO were adopted in the original version of this review because these definitions have proven prognostic value and CSMO has represented for years the main indication for focal or grid laser photocoagulation (<a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a>); although this treatment technique is less used with the advent of antiangiogenic therapy (<a href="./references#CD008081-bbs2-0091" title="VirgiliG , ParravanoM , MenchiniF , EvansJR . Anti‐vascular endothelial growth factor for diabetic macular oedema. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD007419.pub4] ">Virgili 2014</a>). The most common type of CSMO is the central type, defined as retinal thickening within 500 µm of the centre of the macula or, alternatively, hard exudates within 500 µm of the centre of the macula and with thickening of the adjacent retina. The non‐central type of CSMO is less common and is defined as a zone of retinal thickening, one disc area or larger, any portion of which is located within one disc diameter from the centre of the macula. </p> <p>Anatomic lesions different from retinal thickening such as the presence of intraretinal cysts, retinal layer abnormalities (<a href="./references#CD008081-bbs2-0033" title="AlasilT , KeanePA , UpdikeJF , DustinL , OuyangY , WalshAC , et al. Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology2010;117(12):2379‐86. ">Alasil 2010</a>; <a href="./references#CD008081-bbs2-0098" title="YohannanJ , BittencourtM , SepahYJ , HatefE , SophieR , MoradiA , et al. Association of retinal sensitivity to integrity of photoreceptor inner/outer segment junction in patients with diabetic macular edema. Ophthalmology2013;120(6):1254‐61. ">Yohannan 2013</a>), or a thickened posterior vitreous surface adhering to the macula, which is better seen using OCT, have been suggested to be relevant features of DMO in OCT (<a href="./references#CD008081-bbs2-0041" title="ChanA , DukerJS . A standardized method for reporting changes in macular thickening using optical coherence tomography. Archives of Ophthalmology2005;123(7):939‐43. ">Chan 2005</a>). However, there is currently no widely accepted standard to define and report these clinical and OCT aspects and to relate them to the ETDRS definitions of DMO and CSMO, which rely on retinal thickening. Finally, we did not take into account the role of other biomicroscopic findings, including a thickened hyaloid, and their influence on the diagnostic performance of OCT in DMO patients. </p> </section> <section id="CD008081-sec-0041"> <h4 class="title">Reference standards</h4> <p>In the ETDRS study DMO was defined on the basis of stereoscopic fundus photography (<a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a>). This technique is complicated and difficult to use in a clinical setting. It was replaced by contact fundus biomicroscopy, which was found to be in close agreement with stereophotography, particularly for CSMO (<a href="./references#CD008081-bbs2-0064" title="KinyounJ , BartonF , FisherM , HubbardL , AielloL , FerrisF . Detection of diabetic macular edema. Ophthalmoscopy versus photography‐‐Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology1989;96(6):746‐51. ">Kinyoun 1989</a>). Non‐contact fundus biomicroscopy is more commonly used, since sophisticated fundus lenses have been proposed for binocular fundus observation during the past two decades, yet it has been shown to be slightly less sensitive than contact fundus biomicroscopy in the study conducted by Browning et al (<a href="./references#CD008081-bbs2-0002" title="BrowningDJ , McOwenMD , BowenRMJr , O'MarahTL . Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology2004;111(4):712‐5. ">Browning 2004</a>). </p> <p>When this review was conceived, we considered that valid reference tests were stereoscopic fundus photography and contact lens or non‐contact lens biomicroscopy of the fundus. As reported above, in the update of this review, we acknowledge that OCT is increasingly thought of as a new reference standard for DMO (<a href="./references#CD008081-bbs2-0076" title="OlsonJ , SharpP , GoatmanK , PrescottG , ScotlandG , FlemingA , et al. Improving the economic value of photographic screening for optical coherence tomography‐detectable macular oedema: a prospective, multicentre, UK study. Health Technology Assessment2013;17(51):1‐142. ">Olson 2013</a>; <a href="./references#CD008081-bbs2-0077" title="Medical Advisory Secretariat. Optical coherence tomography for age‐related macular degeneration and diabetic macular edema: an evidence‐based analysis. Ontario Health Technology Assessment Series2009; Vol. 9, issue 13:1‐22. ">Ontario HTA 2009</a>) and will not update the review further. Although the American Academy of Ophthalmology’s Preferred Practice Patterns (<a href="./references#CD008081-bbs2-0029" title="American Academy of Ophthalmology Preferred Practice Patterns Committee. Retina Panel. Preferred Practice Patterns: Diabetic Retinopathy. San Francisco, CA: American Academy of Opthalmology2012. ">AAO PPP 2012</a>) still considers clinical examination as the current recommendation for routine diagnosis of DMO, <a href="./references#CD008081-bbs2-0086" title="SchneiderEW , MruthyunjayaP , TalwarN , Harris NwanyanwuK , NanB , SteinJD . Reduced fluorescein angiography and fundus photography use in the management of neovascular macular degeneration and macular edema over the past decade. Investigative Ophthalmology and Visual Science2014;55(1):542‐9. ">Schneider 2013</a> found that the use of OCT has greatly increased for patients with neovascular age‐related macular degeneration or DMO in recent years, while that of fluorescein angiography or fundus photography has decreased. </p> </section> </section> <section id="CD008081-sec-0042"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008081-sec-0043"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Database of Systematic Reviews (CDSR), the Database of Abstracts of Reviews of Effects (DARE), the Health Technology Assessment Database (HTA) and the NHS Economic Evaluation Database (NHSEED) (<i>The Cochrane Library</i> 2013, Issue 5)<i>,</i> Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to June 2013), EMBASE (January 1950 to June 2013), Web of Science Conference Proceedings Citation Index ‐ Science (CPCI‐S) (January 1990 to June 2013), BIOSIS Previews (January 1969 to June 2013), MEDION and the Aggressive Research Intelligence Facility database (ARIF). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 25 June 2013. </p> <p>See: Appendices for details of search strategies for <i>The Cochrane Library</i> (<a href="./appendices#CD008081-sec-0086">Appendix 2</a>), MEDLINE (<a href="./appendices#CD008081-sec-0087">Appendix 3</a>), EMBASE (<a href="./appendices#CD008081-sec-0088">Appendix 4</a>), CPCI‐S (<a href="./appendices#CD008081-sec-0089">Appendix 5</a>), BIOSIS Previews (<a href="./appendices#CD008081-sec-0090">Appendix 6</a>), MEDION (<a href="./appendices#CD008081-sec-0091">Appendix 7</a>) and ARIF (<a href="./appendices#CD008081-sec-0092">Appendix 8</a>). </p> </section> <section id="CD008081-sec-0044"> <h4 class="title">Searching other resources</h4> <p>We handsearched the following journals from 2000 to 2009: American Journal of Ophthalmology; Archives of Ophthalmology; British Journal of Ophthalmology; Investigative Ophthalmology and Visual Science; Ophthalmology and Retina. </p> <p>We also handsearched the references of the articles obtained in full‐text.</p> </section> </section> <section id="CD008081-sec-0045"> <h3 class="title" id="CD008081-sec-0045">Data collection and analysis</h3> <section id="CD008081-sec-0046"> <h4 class="title">Selection of studies</h4> <p>The assessment of the titles and abstracts for eligibility was conducted independently by two review authors. We planned to sort abstracts into 'definitely exclude' and 'possibly include' categories, recognising that sometimes it is not possible to judge from the abstract whether a reference fulfils the criteria or not. All abstracts selected by at least one review author were placed in the 'possibly include' category and we retrieved the corresponding full‐text reports and further independently assessed their eligibility as 'include' or 'exclude'. This was done by two review authors. Disagreements at each step were resolved by discussion between the two review authors and a third senior author. </p> </section> <section id="CD008081-sec-0047"> <h4 class="title">Data extraction and management</h4> <p>We extracted data on the number of:</p> <p> <ul id="CD008081-list-0004"> <li> <p>true positives (TP), i.e. patients categorised as diseased by both the reference and index test; </p> </li> <li> <p>false negatives (FN), i.e. patients categorised as diseased by the reference test, but as non‐diseased by the index test; </p> </li> <li> <p>true negatives (TN), i.e. patients categorised as non‐diseased by both the reference and index tests; </p> </li> <li> <p>false positives (FP), i.e. patients categorised as non‐diseased by the reference test, but as diseased by the index test; </p> </li> <li> <p>patients with uninterpretable index test results;</p> </li> <li> <p>patients with both eyes included in the analyses;</p> </li> <li> <p>missing data, i.e. patients included in the study but not in the analyses, by causes of exclusion. </p> </li> </ul> </p> <p>Uninterpretable OCT results are found when thickness is difficult to obtain because of low quality examinations, such as when ocular media are opaque or the pupil has very poor dilation, or both. For each study, we recorded how these patients were treated in the analyses. </p> <p>The data were extracted independently by two review authors to ensure consistency and entered in to Review Manager (<a href="./references#CD008081-bbs2-0084" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). </p> </section> <section id="CD008081-sec-0048"> <h4 class="title">Assessment of methodological quality</h4> <p>In the updated of this review, the review authors moved to QUADAS 2 (<a href="./references#CD008081-bbs2-0093" title="WhitingPF , RutjesAW , WestwoodME , MallettS , DeeksJJ , ReitsmaJB , et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine2011;155(8):529‐36. ">Whiting 2011</a>) tool to assess the susceptibility to bias of the included studies, based on guidance presented in <a href="./appendices#CD008081-sec-0085">Appendix 1</a>. Additional quality items were on study sponsorship and the unit of analysis issue which is specific to ophthalmology, such as when analyses included both eyes of some individuals. The methodologic quality of the included studies was assessed independently by two review authors and disagreement on study quality was resolved by a third senior author. </p> </section> <section id="CD008081-sec-0049"> <h4 class="title">Statistical analysis and data synthesis</h4> <p>We conducted two separate analyses, one for each definition of the target condition; that is DMO and its more severe form CSMO. </p> <p>We had planned to use the <i>METADAS</i> macro (<a href="./references#CD008081-bbs2-0088" title="TakwoingiY , DeeksJJ . METADAS: A SAS macro for meta‐analysis of diagnostic accuracy studies. Available at srdta.cochrane.org/software‐development. The Cochrane Collaboration, 2008. ">Takwoingi 2008</a>) to fit hierarchical summary ROC curve (HSROC) models in SAS for the primary analysis in this review, as well as to explore the effect of covariates on accuracy and threshold. <a href="./references#CD008081-bbs2-0058" title="HarbordRM , DeeksJJ , EggerM , WhitingP , SterneJA . A unification of models for meta‐analysis of diagnostic accuracy studies. Biostatistics2007;8(2):239‐51. ">Harbord 2007</a> has shown that the bivariate (<a href="./references#CD008081-bbs2-0081" title="ReitsmaJB , GlasAS , RutjesAW , ScholtenRJ , BossuytPM , ZwindermanAH . Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology2005;58(10):982‐90. ">Reitsma 2005</a>) and the HSROC models are mathematically equivalent and, as a result, <i>METADAS</i> derives pooled sensitivity and specificity and the effect of covariates on them. In the original version of this review we used the bivariate model approach to assess the effect of covariates on sensitivity and specificity, since a selection at specified thresholds was planned, and then a meta‐analysis of a few studies including a restricted range of thresholds was possible. As in the original version, when updating this review, we found convergence problems of the bivariate model with some covariates, and decided to fit the HSROC model in SAS but still present the effect of covariates on sensitivity and specificity, as allowed by <i>METADAS</i>. </p> <p>Since DMO is often bilateral, there may be unit of analysis issues in diagnostic studies on this diabetic complication. We originally planned to consider studies as high quality if only one eye of each individual was included or less than 10% of individuals had both eyes included in the study. Studies including patients with both eyes affected but only one randomly selected were also considered as high quality. We planned to conduct subgroup analyses of high versus low quality studies regarding this criterion to investigate heterogeneity. </p> <p>We had planned to refer to <a href="./references#CD008081-bbs2-0051" title="DukicV , GatsonisC . Meta‐analysis of diagnostic test accuracy assessment studies with varying number of thresholds. Biometrics2003;59(4):936‐46. ">Dukic 2003</a> for conducting statistical analyses that included several thresholds extracted from the same study. However, this was not possible even in this update. </p> </section> <section id="CD008081-sec-0050"> <h4 class="title">Investigations of heterogeneity</h4> <p>The investigations were primarily concerned with exploring heterogeneity in sensitivity and specificity as these are the quantities we intended to estimate. Therefore, we used: </p> <p> <ul id="CD008081-list-0005"> <li> <p>forest plots to look for evidence of heterogeneity within sensitivity and within specificity;</p> </li> <li> <p>ROC plots to look for evidence of a threshold effect and heterogeneity due to differences in accuracy; </p> </li> <li> <p>effects of covariates, corresponding to the sources of potential heterogeneity listed in the 'Investigation of sources of heterogeneity' section, on sensitivity or specificity, or both, in the model. </p> </li> </ul> </p> </section> <section id="CD008081-sec-0051"> <h4 class="title">Sensitivity analyses</h4> <p>We planned to restrict analyses by excluding case‐control studies if they were found when updating this review. We also conducted a sensitivity analysis restricted to newer OCT models (Stratus or spectral‐domain OCTs). </p> </section> <section id="CD008081-sec-0052"> <h4 class="title">Assessment of reporting bias</h4> <p>We had planned to assess publication bias using funnel plots displaying lnDOR on the x‐axis and 1/ESS<sup>1/2</sup> (where ESS is the effective sample size) on the y‐axis, as recommended by <a href="./references#CD008081-bbs2-0043" title="DeeksJJ , MacaskillP , IrwigL . The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of Clinical Epidemiology2005;58(9):882‐93. ">Deeks 2005</a>, provided that 10 or more studies were included. However, only nine studies were included in the largest meta‐analysis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008081-sec-0053" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008081-sec-0053"></div> <section id="CD008081-sec-0054"> <h3 class="title" id="CD008081-sec-0054">Results of the search</h3> <p>The original electronic searches yielded a total of 3777 records. After deduplication we screened 1672 titles and abstracts for potential inclusion in the review; we rejected 1652 reports as they were not relevant. Of the two authors who screened the results, one author selected 20 reports for potential inclusion and one author selected 17. After disagreements were discussed with a third review author, we obtained the full‐text copies of 20 studies. Of these, 11 were excluded for reasons presented in the '<a href="http://archie.cochrane.org/sections/documents/view?version=71299967898552733492110603202212%26format=REVMAN#CHARACTERISTICS_OF_EXCLUDED_STUDIES" target="_blank">Characteristics of excluded studies</a>' table and nine met the inclusion criteria for our review since they used an appropriate index and reference test in patients having or not having DMO or CSMO as defined by the ETDRS study. </p> <p>An update search run in June 2013 yielded a further 1178 records (<a href="#CD008081-fig-0001">Figure 1</a>). After deduplication the Trials Search Co‐ordinator scanned 662 records and removed 573 records which were not relevant to the scope of the review. We reviewed 89 records and rejected 81 abstracts as not eligible for inclusion in the review. We obtained full‐text copies of eight reports for further examination. We included one new study (<a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. ">Medina 2012</a>) and excluded seven other studies, see <a href="./references#CD008081-sec-0103" title="">Characteristics of excluded studies</a> table for reasons for exclusion. </p> <div class="figure" id="CD008081-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Results from searching for studies for inclusion in the review." data-id="CD008081-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Results from searching for studies for inclusion in the review.</p> </div> </div> </div> </section> <section id="CD008081-sec-0055"> <h3 class="title">Methodological quality of included studies</h3> <p>Methodological quality is presented in <a href="#CD008081-fig-0002">Figure 2</a>, and details are given in the '<a href="./references#CD008081-sec-0102" title="">Characteristics of included studies</a>' table. </p> <div class="figure" id="CD008081-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study" data-id="CD008081-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study </p> </div> </div> </div> <section id="CD008081-sec-0056"> <h4 class="title">Participant selection</h4> <p>Participant selection was of unclear risk of bias since in four studies it was unclear whether patients were consecutive and only three studies were prospective. Moreover, <a href="./references#CD008081-bbs2-0005" title="GoebelW , FrankeR . Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina2006;26(1):49‐57. ">Goebel 2006</a> included 13 healthy patients (13 eyes) out of 82 participants (137 eyes) and in <a href="./references#CD008081-bbs2-0008" title="NunesS , PereiraI , SantosA , BernardesR , Cunha‐VazJ . Central retinal thickness measured with HD‐OCT shows a weak correlation with visual acuity in eyes with CSME. British Journal of Ophthalmology2010;94(9):1201‐4. ">Nunes 2010</a> all eyes had either central or non‐central CSMO and were drawn from Reading Centre records. The latter is potentially too narrow as a disease spectrum but we believed it was consistent with other studies, which limited the CSMO definition to the central type in all but one study (<a href="./references#CD008081-bbs2-0005" title="GoebelW , FrankeR . Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina2006;26(1):49‐57. ">Goebel 2006</a>). CSMO prevalence varied between 19% and 58% (median 50%) in eight studies and in a ninth study (<a href="./references#CD008081-bbs2-0008" title="NunesS , PereiraI , SantosA , BernardesR , Cunha‐VazJ . Central retinal thickness measured with HD‐OCT shows a weak correlation with visual acuity in eyes with CSME. British Journal of Ophthalmology2010;94(9):1201‐4. ">Nunes 2010</a>) all eyes had either central (N = 40) or non‐central (N = 22) CSMO. Data were extracted for detecting the central type (as 65% prevalence), since all but one of the other studies considered only central CSMO as the target disease. </p> <p>The professional who referred patients was unclear in all studies, although <a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. ">Medina 2012</a> reported referral by primary care. Previous testing and the setting from which patients had been referred was unclear in all studies. Thus, we scored applicability as unclear in all studies. </p> </section> <section id="CD008081-sec-0057"> <h4 class="title">Index test</h4> <p>Five out of 10 studies either did not report masking (blinding) of index test result interpretation (N = 4) or mentioned a lack of masking (N = 1). All but two studies stated the retinal thickness cut off was pre‐specified. Applicability was judged to be good overall regarding index test execution and characteristics. </p> </section> <section id="CD008081-sec-0058"> <h4 class="title">Reference standard</h4> <p>Masking of reference standard results interpretation from index test results was unclear for three studies. The type of reference standard and its execution was appropriate in all studies. </p> </section> <section id="CD008081-sec-0059"> <h4 class="title">Flow and timing</h4> <p>Three out of 10 studies neither reported on uninterpretable results nor explained withdrawals. An additional study (<a href="./references#CD008081-bbs2-0008" title="NunesS , PereiraI , SantosA , BernardesR , Cunha‐VazJ . Central retinal thickness measured with HD‐OCT shows a weak correlation with visual acuity in eyes with CSME. British Journal of Ophthalmology2010;94(9):1201‐4. ">Nunes 2010</a>) gave an unclear explanation of missing data, described as statistical outliers in a primary analysis correlating visual acuity with retinal thickness. The overall proportion of missing data for any cause, that is the differences between eyes included in the study and those analysed, was 0% to 9% in five studies reporting on them (thus, below the 10% threshold which we planned to use for subgroup analyses) and was 11% in a sixth study (<a href="./references#CD008081-bbs2-0008" title="NunesS , PereiraI , SantosA , BernardesR , Cunha‐VazJ . Central retinal thickness measured with HD‐OCT shows a weak correlation with visual acuity in eyes with CSME. British Journal of Ophthalmology2010;94(9):1201‐4. ">Nunes 2010</a>). </p> </section> <section id="CD008081-sec-0060"> <h4 class="title">Additional quality items</h4> <p>Unit of analysis was an issue, which was recorded as poor quality for all studies but <a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. ">Medina 2012</a>, since the proportion of patients with both eyes in the analysis was 68% to 95%. <a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. ">Medina 2012</a> included only one eye of 62 patients. Failure to take into account the correlation between eyes of the same patient can lead to too narrow estimates of the standard error of sensitivity and specificity in the studies. Thus, 95% CIs of summary sensitivity and specificity in our review should be wider. Although <a href="./references#CD008081-bbs2-0003" title="CampbellRJ , CouplandSG , Buhrmann , RR , KertesPJ . Effect of eccentric and inconsistent fixation on retinal optical coherence tomography measures. Archives of Ophthalmology2007;125(5):619‐23. ">Campbell 2007</a> provided sensitivity and specificity estimates adjusting for within subject correlation, using the design effect correction factor we extrapolated data using the total number of eyes, rather than participants, to be able to include this study in this review. </p> <p>There were no overt declarations of potential conflicts of interest in terms of the manufacturer of the OCT device being involved in funding the research. </p> </section> </section> <section id="CD008081-sec-0061"> <h3 class="title" id="CD008081-sec-0061">Findings</h3> <p>Ten studies included a total of 830 participants and 1436 eyes, of which 1387 eyes contributed to the analyses (49 eyes were missing or excluded). All studies used OCT to measure central retinal thickness. In addition, <a href="./references#CD008081-bbs2-0003" title="CampbellRJ , CouplandSG , Buhrmann , RR , KertesPJ . Effect of eccentric and inconsistent fixation on retinal optical coherence tomography measures. Archives of Ophthalmology2007;125(5):619‐23. ">Campbell 2007</a> also used retinal volume as an outcome measure ‐ stating that it was slightly superior to thickness ‐ but without a formal statistical comparison. For this reason we reported only on the use of central retinal thickness as the OCT outcome measure (<a href="./full#CD008081-tbl-0001">summary of findings Table</a>). </p> <p>Five studies adopted the diagnostic accuracy paradigm in their analysis (<a href="./references#CD008081-bbs2-0003" title="CampbellRJ , CouplandSG , Buhrmann , RR , KertesPJ . Effect of eccentric and inconsistent fixation on retinal optical coherence tomography measures. Archives of Ophthalmology2007;125(5):619‐23. ">Campbell 2007</a>; <a href="./references#CD008081-bbs2-0005" title="GoebelW , FrankeR . Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina2006;26(1):49‐57. ">Goebel 2006</a>; <a href="./references#CD008081-bbs2-0006" title="HeeMR , PuliafitoCA , DukerJS , ReichelE , CokerJG , WilkinsJR , et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology1998;105(2):360‐70. ">Hee 1998</a>; <a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. ">Medina 2012</a>; <a href="./references#CD008081-bbs2-0009" title="SaddaSR , TanO , WalshAC , SchumanJS , VarmaR , HuangD . Automated detection of clinically significant macular edema by grid scanning optical coherence tomography. Ophthalmology2006;113(7):1187‐96. ">Sadda 2006</a>) and five analysed data in terms of agreement, thus assuming that neither test was preferable (<a href="./references#CD008081-bbs2-0001" title="BrownJC , SolomonSD , BresslerSB , SchachatAP , DiBernardoC , BresslerNM . Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. Archives of Ophthalmology2004;122(3):330‐5. ">Brown 2004</a>; <a href="./references#CD008081-bbs2-0002" title="BrowningDJ , McOwenMD , BowenRMJr , O'MarahTL . Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology2004;111(4):712‐5. ">Browning 2004</a>; <a href="./references#CD008081-bbs2-0004" title="DavisMD , BresslerSB , AielloLP , BresslerNM , BrowningDJ , FlaxelCJ , et al. Diabetic Retinopathy Clinical Research Network Study Group. Comparison of time‐domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Investigative Ophthalmology and Visual Science2008;49(5):1745‐52. ">Davis 2008</a>; <a href="./references#CD008081-bbs2-0008" title="NunesS , PereiraI , SantosA , BernardesR , Cunha‐VazJ . Central retinal thickness measured with HD‐OCT shows a weak correlation with visual acuity in eyes with CSME. British Journal of Ophthalmology2010;94(9):1201‐4. ">Nunes 2010</a>; <a href="./references#CD008081-bbs2-0010" title="StromC , SanderB , LarsenN , LarsenM , Lund‐AndersenH . Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Investigative Ophthalmology and Visual Science2002;43(1):241‐5. ">Strom 2002</a>). </p> <p>Although all patients were seen at specialised retina clinics, only <a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. ">Medina 2012</a> mentioned referral by primary care practitioners, but how the referral decision was made and what test was used were unclear. </p> <section id="CD008081-sec-0062"> <h4 class="title">Diagnosis of CSMO</h4> <p>Nine studies provided data on 1303 eyes for the analysis on CSMO (<a href="#CD008081-fig-0003">Figure 3</a>; <a href="#CD008081-fig-0004">Figure 4</a>; <a href="./full#CD008081-tbl-0001">summary of findings Table</a>), which is the most severe form of DMO requiring treatment. The meta‐analytic summary estimates corresponded to a sensitivity of 0.81 (95% CI 0.74 to 0.86) and a specificity of 0.85 (95% CI 0.75 to 0.91). The positive likelihood ratio was 5.3 (3.2 to 8.7), the negative likelihood ratio was 0.23 (0.18 to 0.30) and the diagnostic odds ratio (DOR) was 23 (13 to 40). Using OCT in a sample of 1000 people, of which 500 have CSMO, will lead to missing 98 patients (false negatives) and will over‐diagnose 77 patients (false positives). </p> <div class="figure" id="CD008081-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of OCT for detection of CSMO." data-id="CD008081-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of OCT for detection of CSMO.</p> </div> </div> </div> <div class="figure" id="CD008081-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Summary ROC Plot of OCT for detection of CSMO." data-id="CD008081-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary ROC Plot of OCT for detection of CSMO.</p> </div> </div> </div> <section id="CD008081-sec-0063"> <h5 class="title">Subgroup and sensitivity analyses for diagnosis of CSMO</h5> <p>Among relevant pre‐planned covariates, no overall effect of low risk of bias (vs unclear and high risk of bias) could be demonstrated for any QUADAS 2 domain, with P values larger than 0.6 in all analyses. </p> <p>We present subgroup analyses for other covariates in <a href="#CD008081-tbl-0002">Table 1</a>. Only prevalence had a statistically significant effect on the overall model parameters, but including the study at median prevalence (<a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. ">Medina 2012</a>; 50% patients with CSMO) in the high prevalence (P = 0.011) or low prevalence (P = 0.109) group caused the overall covariate effect to cross the nominal statistical significance threshold. </p> <div class="table" id="CD008081-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Subgroup analyses</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Covariate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Subgroup</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall P values vs no subgroups</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Retinal thickness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≤ 250 µm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86 (0.76 to 0.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (0.75 to 0.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 250 µm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77 (0.69 to 0.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (0.64 to 0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.971</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.034</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Prevalence</b> </p> <p><b>(</b><a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. "><b>Medina 2012</b> </a><b> in high prevalence group)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≥ 50% (50% to 65%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86 (0.81 to 0.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74 (0.64 to 9.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 50% (19% to 45%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74 (0.68 to 0.80)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (0.84 to 0.97)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.011</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Prevalence</b> </p> <p><b>(</b><a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. "><b>Medina 2012</b> </a><b> in low prevalence group)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 50% (56% to 65%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86 (0.81 to 0.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 (0.57 to 0.83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≤ 50% (19% to 50%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74 (0.69 to 0.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (0.84 to 0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.109</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Reference standard</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Biomicroscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.78 (0.69 to 0.86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.79 to 0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Photography or both</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 (0.74 to 0.88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79 (0.64 to 0.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.653</p> </td> </tr> </tbody> </table> </div> <p>The exclusion of two studies (<a href="./references#CD008081-bbs2-0005" title="GoebelW , FrankeR . Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina2006;26(1):49‐57. ">Goebel 2006</a>; <a href="./references#CD008081-bbs2-0006" title="HeeMR , PuliafitoCA , DukerJS , ReichelE , CokerJG , WilkinsJR , et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology1998;105(2):360‐70. ">Hee 1998</a>) using an obsolete OCT model (OCT 2000) did not change the pooled estimate (sensitivity: 0.83, 95% CI 0.75 to 0.88; specificity: 0.85; 95% CI 0.72 to 0.93). </p> </section> <section id="CD008081-sec-0064"> <h5 class="title">Additional information on completeness of reporting</h5> <section id="CD008081-sec-0065"> <h6 class="title">Retinal thickness cut‐off</h6> <p>We describe in more detail how studies reported and analysed accuracy at different retinal thickness thresholds since this is a key issue for applicability. In fact, macular thickness cut‐off with OCT was variably reported. <a href="./references#CD008081-bbs2-0001" title="BrownJC , SolomonSD , BresslerSB , SchachatAP , DiBernardoC , BresslerNM . Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. Archives of Ophthalmology2004;122(3):330‐5. ">Brown 2004</a> presented a figure with cut‐offs at 200 µm, 300 µm and 400 µm. <a href="./references#CD008081-bbs2-0002" title="BrowningDJ , McOwenMD , BowenRMJr , O'MarahTL . Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology2004;111(4):712‐5. ">Browning 2004</a> used the upper limit of the normal range for each subfield (265 µm for the central subfield). <a href="./references#CD008081-bbs2-0003" title="CampbellRJ , CouplandSG , Buhrmann , RR , KertesPJ . Effect of eccentric and inconsistent fixation on retinal optical coherence tomography measures. Archives of Ophthalmology2007;125(5):619‐23. ">Campbell 2007</a> reported on cut‐offs from 190 µm to 240 µm, and we used the thickest value because it was the closest to those pre‐specified in this review. <a href="./references#CD008081-bbs2-0004" title="DavisMD , BresslerSB , AielloLP , BresslerNM , BrowningDJ , FlaxelCJ , et al. Diabetic Retinopathy Clinical Research Network Study Group. Comparison of time‐domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Investigative Ophthalmology and Visual Science2008;49(5):1745‐52. ">Davis 2008</a> used a cut‐off of 246 µm and quoted an unpublished study on 260 individuals, conducted by the OCT producer, which found that this was the upper limit for normality (mean + 2 standard deviations (SDs); we rounded this up to 250 µm for descriptive purposes). <a href="./references#CD008081-bbs2-0005" title="GoebelW , FrankeR . Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina2006;26(1):49‐57. ">Goebel 2006</a> used a cut‐off of 230 µm for the central subfield. <a href="./references#CD008081-bbs2-0006" title="HeeMR , PuliafitoCA , DukerJS , ReichelE , CokerJG , WilkinsJR , et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology1998;105(2):360‐70. ">Hee 1998</a> presented a figure with the crude number of eyes with and without CSMO at 25 µm from 100 µm to 800 µm, and we extracted data at a cut‐off of 250 µm because it was the most commonly used in studies included in this review. <a href="./references#CD008081-bbs2-0009" title="SaddaSR , TanO , WalshAC , SchumanJS , VarmaR , HuangD . Automated detection of clinically significant macular edema by grid scanning optical coherence tomography. Ophthalmology2006;113(7):1187‐96. ">Sadda 2006</a> used the MG5 algorithm to detect both central and non‐central CSMO and provided data separately for both types; they used a cut‐off of 300 µm for central CSMO and we used this value for the whole sample in subgroup analyses by retinal thickness cut‐off because sensitivity and specificity were nearly identical for the two types of CSMO. <a href="./references#CD008081-bbs2-0008" title="NunesS , PereiraI , SantosA , BernardesR , Cunha‐VazJ . Central retinal thickness measured with HD‐OCT shows a weak correlation with visual acuity in eyes with CSME. British Journal of Ophthalmology2010;94(9):1201‐4. ">Nunes 2010</a> used a cut‐off of 262 µm computed as two standard deviations above mean thickness of an age‐matched control population of 29 eyes of healthy volunteers. <a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. ">Medina 2012</a> compared three different spectral domain OCT models as well as measurements in mydriasis and myosis and reported the best cut‐off in the central and eight paracentral fields. </p> <p>No definite sensitivity and specificity pattern was apparent for the two subgroups of studies using cut‐offs above or below 250 µm (<a href="#CD008081-tbl-0002">Table 1</a>), which is not surprising given the narrow range of thickness cut‐offs (230 µm to 300 µm), which are clinically similar. In fact, retinal thickness values in people with CSMO often range between 300 µm and 600 µm, or even more. </p> </section> <section id="CD008081-sec-0066"> <h6 class="title">Missing data</h6> <p>Information on missing data, that is participants included in the study but not analysed, was available for <a href="./references#CD008081-bbs2-0001" title="BrownJC , SolomonSD , BresslerSB , SchachatAP , DiBernardoC , BresslerNM . Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. Archives of Ophthalmology2004;122(3):330‐5. ">Brown 2004</a> (3%), <a href="./references#CD008081-bbs2-0004" title="DavisMD , BresslerSB , AielloLP , BresslerNM , BrowningDJ , FlaxelCJ , et al. Diabetic Retinopathy Clinical Research Network Study Group. Comparison of time‐domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Investigative Ophthalmology and Visual Science2008;49(5):1745‐52. ">Davis 2008</a> (6%), <a href="./references#CD008081-bbs2-0005" title="GoebelW , FrankeR . Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina2006;26(1):49‐57. ">Goebel 2006</a> (9%), and <a href="./references#CD008081-bbs2-0008" title="NunesS , PereiraI , SantosA , BernardesR , Cunha‐VazJ . Central retinal thickness measured with HD‐OCT shows a weak correlation with visual acuity in eyes with CSME. British Journal of Ophthalmology2010;94(9):1201‐4. ">Nunes 2010</a> (11%) at the eye level. There were no missing data for <a href="./references#CD008081-bbs2-0003" title="CampbellRJ , CouplandSG , Buhrmann , RR , KertesPJ . Effect of eccentric and inconsistent fixation on retinal optical coherence tomography measures. Archives of Ophthalmology2007;125(5):619‐23. ">Campbell 2007</a> and <a href="./references#CD008081-bbs2-0010" title="StromC , SanderB , LarsenN , LarsenM , Lund‐AndersenH . Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Investigative Ophthalmology and Visual Science2002;43(1):241‐5. ">Strom 2002</a>. Such information was not fully available for <a href="./references#CD008081-bbs2-0002" title="BrowningDJ , McOwenMD , BowenRMJr , O'MarahTL . Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology2004;111(4):712‐5. ">Browning 2004</a>, <a href="./references#CD008081-bbs2-0006" title="HeeMR , PuliafitoCA , DukerJS , ReichelE , CokerJG , WilkinsJR , et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology1998;105(2):360‐70. ">Hee 1998</a> and <a href="./references#CD008081-bbs2-0009" title="SaddaSR , TanO , WalshAC , SchumanJS , VarmaR , HuangD . Automated detection of clinically significant macular edema by grid scanning optical coherence tomography. Ophthalmology2006;113(7):1187‐96. ">Sadda 2006</a>. Owing to incomplete reporting of the various types of missing data and the small amount when reported, we did not undertake subgroup analyses for this item as planned in the protocol. We observed that the overall proportion of missing data was small, when reported, although this may impact sensitivity and specificity estimates since few counts are often recorded at their numerator. </p> </section> </section> </section> <section id="CD008081-sec-0067"> <h4 class="title">Diagnosis of DMO</h4> <p>Three studies provided data on 258 eyes included in this analysis on DMO (<a href="#CD008081-fig-0005">Figure 5</a>). Sensitivities were 0.78 (95% CI 0.66 to 0.87), 0.84 (95% CI 0.70 to 0.93) and 1.00 (95% CI 0.77 to 1.00), and specificities were 0.82 (95% CI 0.66 to 0.92), 0.79 (95% CI 0.54 to 0.94), and 1.00 (95% CI 0.95 to 1.00), respectively, in <a href="./references#CD008081-bbs2-0005" title="GoebelW , FrankeR . Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina2006;26(1):49‐57. ">Goebel 2006</a>; <a href="./references#CD008081-bbs2-0009" title="SaddaSR , TanO , WalshAC , SchumanJS , VarmaR , HuangD . Automated detection of clinically significant macular edema by grid scanning optical coherence tomography. Ophthalmology2006;113(7):1187‐96. ">Sadda 2006</a>, and <a href="./references#CD008081-bbs2-0010" title="StromC , SanderB , LarsenN , LarsenM , Lund‐AndersenH . Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. Investigative Ophthalmology and Visual Science2002;43(1):241‐5. ">Strom 2002</a>; the latter reported perfect sensitivity and specificity. We did not compute pooled estimates of sensitivity and specificity of OCT to detect DMO because only three studies provided data for this analysis; one of which yielded a perfect performance. </p> <div class="figure" id="CD008081-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of OCT for detection of DMO." data-id="CD008081-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of OCT for detection of DMO.</p> </div> </div> </div> </section> <section id="CD008081-sec-0068"> <h4 class="title">Disagreements between OCT and fundus biomicroscopy</h4> <p>As reported before, the diagnostic accuracy framework is valid if the clinical reference standard is the best available method for establishing the presence or absence of the target (<a href="./references#CD008081-bbs2-0037" title="BossuytPM , LeeflangMM . Chapter 6: Developing criteria for including studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The Cochrane Collaboration, 2008. ">Bossuyt 2008</a>) and implies that, in patients with discordant results, the reference standard is true and the index test is wrong. The included study <a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. ">Medina 2012</a> is a recent example of a study in which such a diagnostic accuracy question has been made again on OCT testing for DMO. In these cases, it is important to investigate whether additional information is offered by the newer, or index, test in case of disagreements. </p> <p>We did not find studies which used both OCT and fundus photography or biomicroscopy to detect CSMO and simultaneously tried to resolve all disagreements using a fair 'umpire' test, such as concurrent testing, prognosis or treatment response, a methodology which has been advised to accept a new diagnostic test as a better reference standard (<a href="./references#CD008081-bbs2-0056" title="GlasziouP ,  IrwigL , DeeksJJ . When should a new test become the current reference standard?. Annals of Internal Medicine2008;149(11):816‐21. ">Glasziou 2008</a>). <a href="./references#CD008081-bbs2-0046" title="BrowningDJ , GlassmanAR , AielloLP , BeckRW , BrownDM , FongDS , et al. Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography‐measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology2007;114(3):525‐36. ">DRCR Network 2007c</a> compared the correlation of OCT and photography with visual acuity, both cross‐sectionally and longitudinally, but did not use the standard CSMO definition and did not specifically address disagreements. Hereafter we report on some useful studies on spectrum of disease and prognosis in cases of disagreement between our index and reference tests (<a href="./references#CD008081-bbs2-0036" title="BhavsarKV , SubramanianML . Risk factors for progression of subclinical diabetic macular oedema. British Journal of Ophthalmology2011;95(5):671‐4. ">Bhavsar 2011</a>; <a href="./references#CD008081-bbs2-0038" title="BrowningDJ , FraserCM . The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. American Journal of Ophthalmology2008;145(1):149‐54. ">Browning 2008a</a>; <a href="./references#CD008081-bbs2-0039" title="BrowningDJ , FraserCM , ClarkS . The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology2008;115(3):533–9. ">Browning 2008b</a>; <a href="./references#CD008081-bbs2-0049" title="BresslerNM , MillerKM , BeckRW , BresslerSB , GlassmanAR , KitchensJW , et al. Diabetic Retinopathy Clinical Research Network. Observational study of subclinical diabetic macular edema. Eye2012;26(6):833‐40. ">DRCR Network 2012</a>; <a href="./references#CD008081-bbs2-0080" title="PiresI , SantosAR , NunesS , LoboC , Cunha‐VazJ . Subclinical macular edema as a predictor of progression to clinically significant macular edema in type 2 diabetes. Ophthalmologica2013;230(4):201‐6. ">Pires 2013</a>), which are useful to examine the characteristics of OCT false positives which disagree with fundus biomicroscopy or photography on the existence of CSMO. </p> <p><a href="./references#CD008081-bbs2-0039" title="BrowningDJ , FraserCM , ClarkS . The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology2008;115(3):533–9. ">Browning 2008b</a> reported on retinal thickening in 100 healthy people and 283 diabetic patients without clinically detected macular oedema. They found OCT central retinal thickness exceeding the normal range in 6% of patients with DR, nearly all of whom had thickness values below 300 µm according to presented data. Such thickness values are within the range of cut‐offs used in studies included in this review, and in the low range of OCT retinal thickening recorded in patients with macular oedema, which may reach values as high as 600 µm to 1000 µm. <a href="./references#CD008081-bbs2-0039" title="BrowningDJ , FraserCM , ClarkS . The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology2008;115(3):533–9. ">Browning 2008b</a> also suggested that more cases of OCT thickening are found in people with severe non‐proliferative retinopathy. This means that disagreements are more common in patients who were not included in <a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a>, who had mild to moderate retinopathy. On the other hand, this is a retrospective, single physician study and retinopathy subgroups were relatively small. </p> <p>More interestingly, <a href="./references#CD008081-bbs2-0038" title="BrowningDJ , FraserCM . The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. American Journal of Ophthalmology2008;145(1):149‐54. ">Browning 2008a</a> reported on the follow‐up of 153 patients with subclinical DMO, i.e. eyes with OCT thickening of the macula but not meeting the CSMO definition, who had good visual acuity and baseline central thickness of 238 µm (SD 39 µm). They did not report on visual acuity in detail but found that about a third of these patients progressed to CSMO within 35 months (median follow‐up 14 months), then received laser treatment. The authors commented that "subclinical DMO does not inexorably progress, and when it progresses, tends to do so slowly". These patients may resemble those with questionable CSMO or minimal non‐central macular thickening in <a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a>, who were both at less risk of visual loss and had less or no benefit from photocoagulation laser compared to those with definite oedema (<a href="./references#CD008081-bbs2-0053" title="Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Archives of Ophthalmology1995;113(9):1144‐55. ">ETDRS 1995</a>). </p> <p>Further research has confirmed these findings. <a href="./references#CD008081-bbs2-0049" title="BresslerNM , MillerKM , BeckRW , BresslerSB , GlassmanAR , KitchensJW , et al. Diabetic Retinopathy Clinical Research Network. Observational study of subclinical diabetic macular edema. Eye2012;26(6):833‐40. ">DRCR Network 2012</a> screened 891 eyes among 582 study participants and found that 43 eyes (4.8%) of 39 participants had OCT central retinal thickness between 225 µm and 299 µm. Nine of 43 eyes (21%) required treatment for DMO by 2 years, whereas 27% and 38% were estimated to either have been treated or have met an OCT worsening criterion (i.e. thickness increased by 50 µm or becoming 300 µm or more) at the one or two year visit. Nonetheless, average visual acuity was unchanged at the time of progression in these patients. </p> <p>In 348 eyes with type 2 diabetes and non‐proliferative diabetic retinopathy, <a href="./references#CD008081-bbs2-0080" title="PiresI , SantosAR , NunesS , LoboC , Cunha‐VazJ . Subclinical macular edema as a predictor of progression to clinically significant macular edema in type 2 diabetes. Ophthalmologica2013;230(4):201‐6. ">Pires 2013</a> found that 6 out of 32 eyes/patients presenting subclinical DMO at baseline developed CSMO (18.7%), while 20 out of 316 eyes without subclinical DMO developed CSMO (6.3%) within two years. </p> <p><a href="./references#CD008081-bbs2-0036" title="BhavsarKV , SubramanianML . Risk factors for progression of subclinical diabetic macular oedema. British Journal of Ophthalmology2011;95(5):671‐4. ">Bhavsar 2011</a> followed for an average of 19 months a total 124 eyes of 73 diabetic patients of whom 52 eyes of 37 diabetic patients with subclinical CSMO in one or both eyes, whereas a control group included 72 eyes of 36 patients without macular oedema. Sixteen eyes of 13 subjects (35%) progressed to CSMO in the study group, compared with six eyes of four subjects (11%) in the control group. They found a 15% increase in odds of progression with each 10 μm increase in central macular thickness. Thus, we agree with <a href="./references#CD008081-bbs2-0038" title="BrowningDJ , FraserCM . The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. American Journal of Ophthalmology2008;145(1):149‐54. ">Browning 2008a</a> that such extra cases should be monitored more closely. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008081-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008081-sec-0069"></div> <section id="CD008081-sec-0070"> <h3 class="title" id="CD008081-sec-0070">Summary of main results</h3> <p>The results of this review must be interpreted in relation to the role of OCT and clinical fundus examination in the diagnostic pathway, a role that has evolved over time. The first two of the following paragraphs, and also the <a href="./full#CD008081-tbl-0001">summary of findings Table</a>, adopt the diagnostic accuracy perspective with clinical fundus examination as reference standard, i.e. the true result in case of disagreement with the index test. The third of the following paragraphs summarises the literature on the additional information offered by measuring OCT central thickness with respect to clinical examination, in support of its use as a new reference standard for diagnosing DMO. </p> <section id="CD008081-sec-0071"> <h4 class="title">OCT for detecting CSMO</h4> <p>Our systematic review of 10 studies found that central retinal thickness measured with OCT is not sensitive enough (0.81) nor specific enough (0.85) to detect the central type of CSMO defined using fundus examination or photography according to the conventional ETDRS definition, which has guided for decades the use of laser photocoagulation, until antiangiogenic therapy became available. Of 1000 people, 500 of whom have CSMO, a substantial proportion would be missed (N = 98), and there would be some over‐referrals (N = 77) (<a href="./full#CD008081-tbl-0001">summary of findings Table</a>). The thickness cut‐off extracted from studies included in this review ranged between 230 µm and 300 µm, and was a median of 250 µm. The precision of summary sensitivity and specificity estimates in this review are likely to be inflated by the fact that both eyes of most patients were included in the studies without accounting for within patient correlation. </p> <p>In the original version of this review, prevalence was found to have an effect on threshold so that OCT tended to be more specific and less sensitive in studies with lower CSMO prevalence (&lt; 50%). Among mechanisms that may be responsible for sensitivity and specificity varying with prevalence (<a href="./references#CD008081-bbs2-0066" title="LeeﬂangMM , BossuytPM , IrwigL . Diagnostic test accuracy may vary with prevalence:implications for evidence‐based diagnosis. Journal of Cllinical Epidemiology2009;62(1):5‐12. ">Leeflang 2009</a>), patient spectrum and reference standard misclassification may apply to this review. However, in this update we found such analysis to be sensitive to the inclusion of a new study (<a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. ">Medina 2012</a>), in which CSMO prevalence was at the median value among nine studies, in the high or low prevalence subgroups. </p> </section> <section id="CD008081-sec-0072"> <h4 class="title">OCT for detecting DMO</h4> <p>There were only three studies reporting on accuracy of OCT to detect DMO. Two studies found moderate sensitivity and specificity (about 80%) and a third study found perfect sensitivity and specificity (both equal to 1). Since estimates were heterogeneous across studies, a meta‐analysis was not performed. </p> </section> <section id="CD008081-sec-0073"> <h4 class="title">Role of OCT as a new reference standard for detecting DMO</h4> <p>While the original version of this review assumed that deciding upon laser photocoagulation was an appropriate decision making context for using OCT, since the biomicroscopic ETDRS definition of CSMO has been used for more than three decades for this purpose (<a href="./references#CD008081-bbs2-0052" title="Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Archives of Ophthalmology1985;103(12):1796‐806. ">ETDRS 1985</a>; <a href="./references#CD008081-bbs2-0053" title="Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Archives of Ophthalmology1995;113(9):1144‐55. ">ETDRS 1995</a>), in this update of the review we re‐examined the use of OCT based on studies suggesting that central retinal thickness measures with OCT can be considered a new, objective reference standard for diagnosing DMO (<a href="./references#CD008081-bbs2-0076" title="OlsonJ , SharpP , GoatmanK , PrescottG , ScotlandG , FlemingA , et al. Improving the economic value of photographic screening for optical coherence tomography‐detectable macular oedema: a prospective, multicentre, UK study. Health Technology Assessment2013;17(51):1‐142. ">Olson 2013</a>; <a href="./references#CD008081-bbs2-0077" title="Medical Advisory Secretariat. Optical coherence tomography for age‐related macular degeneration and diabetic macular edema: an evidence‐based analysis. Ontario Health Technology Assessment Series2009; Vol. 9, issue 13:1‐22. ">Ontario HTA 2009</a>). Specifically, several studies have shown that extra cases of DMO detected by OCT, but not by fundus examination, i.e. the so called subclinical DMO, are to be followed up closely due to the increased risk of developing CSMO. Furthermore, RCTs demonstrating the superiority of antiangiogenic therapy over laser photocoagulation (<a href="./references#CD008081-bbs2-0091" title="VirgiliG , ParravanoM , MenchiniF , EvansJR . Anti‐vascular endothelial growth factor for diabetic macular oedema. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD007419.pub4] ">Virgili 2014</a>) have established the primary role of OCT testing for monitoring treatment response, and, thus, in clinical practice. Finally, since OCT is acknowledged by many to be the new reference standard for diagnosing DMO, this review will no longer be updated. </p> </section> </section> <section id="CD008081-sec-0074"> <h3 class="title" id="CD008081-sec-0074">Strengths and weaknesses of the review</h3> <section id="CD008081-sec-0075"> <h4 class="title">Strengths</h4> <p>Merits of this review are a comprehensive literature search, the quality assessment of studies and a meta‐analytic summary estimate of diagnostic accuracy based on recommended methodology. </p> </section> <section id="CD008081-sec-0076"> <h4 class="title">Weaknesses</h4> <p>The main weakness of this review is related to the fact that no clinical pathway could be pre‐specified, nor was it reported in any included study, and that the role of OCT has changed over the last decade, gaining importance in the diagnostics of chorioretinal disease. </p> <p>The number of studies in this review is small and only two studies adopted the latest generation OCTs, which also record slightly higher values of retinal thickness compared with the Stratus OCT (<a href="./references#CD008081-bbs2-0054" title="ForooghianF , CukrasC , MeyerleCB , ChewEY , WongWT . Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Investigative Ophthalmology and Visual Science2008;49(10):4290‐6. ">Forooghian 2008</a>; <a href="./references#CD008081-bbs2-0061" title="KiernanDF , HariprasadSM , ChinEK , KiernanCL , RagoJ , MielerWF . Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness. American Journal of Ophthalmology2009;147(2):267‐75. ">Kiernan 2009</a>; <a href="./references#CD008081-bbs2-0096" title="Wolf‐SchnurrbuschUE , CeklicL , BrinkmannCK , IlievME , FreyM , RothenbuehlerSP , et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Investigative Ophthalmology and Visual Science2009;50(7):3432‐7. ">Wolf‐Schnurrbusch 2009</a>), and two studies used an obsolete OCT model (OCT 2000), although their exclusion did not change the pooled estimate in a sensitivity analysis. <a href="./references#CD008081-bbs2-0067" title="LiuMM , WolfsonY , BresslerSB , DoDV , YingHS , BresslerNM . Comparison of time‐ and spectral‐domain optical coherence tomography in management of diabetic macular edema. Investigative Ophthalmology and Visual Science2014;55(3):1370‐7. ">Liu 2014</a> investigated decision‐making on monitoring antiangiogenic therapy for DMO and found that newer spectral domain OCTs rarely lead to different treatment decisions compared to the Stratus OCT. </p> <p>More importantly, we could not investigate the effect at pre‐specified retinal thickness cut‐offs on sensitivity and specificity because data were not available in the included studies. </p> <p>Another limitation of this review is that we could not obtain data for individuals as the unit of analysis, as nine studies included both eyes of the majority of patients and treated them as if they were independent of each other. Therefore, summary estimates of sensitivity and specificity will have too narrow CIs because the correlation between eyes of the same individual was not taken into account. Apart from this item, at least one QUADAS 2 domain was at unclear or high risk of bias in all studies. </p> </section> <section id="CD008081-sec-0077"> <h4 class="title">Completeness of the evidence on the use of OCT central retinal thickness as reference standard </h4> <p>We did not search systematically the literature on disagreements between OCT and clinical fundus examination. However, we found several studies showing that evidence is accumulating on prognosis and treatment of subclinical DMO cases detected with OCT, i.e. false positives in our review. </p> <p>We found no studies on clinical and OCT findings of OCT false negatives, i.e. cases in which ophthalmologist's fundus examination but not OCT identifies DMO or CSMO. This problem is particularly important for its use in the primary care setting, since these could be missed referrals exposed to consequences of lack of treatment until they are detected. Moreover, we found no observational studies on the consequences of withholding treatment in these patients, that is those with CSMO who did not have central thickening on OCT (nearly 8% at an average CSMO prevalence of 50% in our review). A potential cause of false negative OCT results may be the fact that, with the exception of <a href="./references#CD008081-bbs2-0009" title="SaddaSR , TanO , WalshAC , SchumanJS , VarmaR , HuangD . Automated detection of clinically significant macular edema by grid scanning optical coherence tomography. Ophthalmology2006;113(7):1187‐96. ">Sadda 2006</a>, the included studies assessed only the central type of CSMO. Although this was made explicit, it is unclear how in reality clinicians applying the reference standard were able to handle overlapping with the non‐central type of CSMO, which is less common and is also influenced by detection of hard exudates, which are not included in the definition of OCT thickness‐based positivity but would be identified by concurrent fundus imaging. </p> </section> </section> <section id="CD008081-sec-0078"> <h3 class="title" id="CD008081-sec-0078">Applicability of findings to the review question</h3> <p>Readers who wish to use and interpret the results of this review should consider the setting and clinical pathway to which they could be applied. The studies included in this review were carried out in tertiary care settings and patients had a high prevalence of CSMO, around 50%. Furthermore, we found that OCT sensitivity decreased and its specificity increased at lower prevalence, usually associated with milder disease profile, but this subgroup analysis may not be reliable as it was based on few studies. </p> <p>Newer spectral‐domain OCT devices have higher resolution than previous devices and may show further abnormalities of the retinal layers, including those of the photoreceptor layer (<a href="./references#CD008081-bbs2-0033" title="AlasilT , KeanePA , UpdikeJF , DustinL , OuyangY , WalshAC , et al. Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology2010;117(12):2379‐86. ">Alasil 2010</a>; <a href="./references#CD008081-bbs2-0098" title="YohannanJ , BittencourtM , SepahYJ , HatefE , SophieR , MoradiA , et al. Association of retinal sensitivity to integrity of photoreceptor inner/outer segment junction in patients with diabetic macular edema. Ophthalmology2013;120(6):1254‐61. ">Yohannan 2013</a>). However, because the construct underlying DMO and CSMO is that of thickening, we only considered thickness‐related measures in this review. </p> <p>Some recent RCTs on anti‐VEGF treatment for macular oedema due to DR have included patients in whom our index test and reference standard were both positive, that is affected by clinically detected CSMO and central retinal thickening on OCT (<a href="./references#CD008081-bbs2-0048" title="ElmanMJ , AielloLP , BeckRW , BresslerNM , BresslerSB , EdwardsAR , et al. Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology2010;117(6):1064‐77. ">DRCR Network 2010</a>; <a href="./references#CD008081-bbs2-0082" title="MassinP , BandelloF , GarwegJG , HansenLL , HardingSP , LarsenM , et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12‐month, randomized, controlled, double‐masked, multicenter phase II study. Diabetes Care2010;33(11):2399‐405. ">RESOLVE 2010</a>). Also, changes in OCT retinal thickness were used to decide on the need for ranibizumab re‐treatment in <a href="./references#CD008081-bbs2-0048" title="ElmanMJ , AielloLP , BeckRW , BresslerNM , BresslerSB , EdwardsAR , et al. Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology2010;117(6):1064‐77. ">DRCR Network 2010</a> and <a href="./references#CD008081-bbs2-0082" title="MassinP , BandelloF , GarwegJG , HansenLL , HardingSP , LarsenM , et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12‐month, randomized, controlled, double‐masked, multicenter phase II study. Diabetes Care2010;33(11):2399‐405. ">RESOLVE 2010</a>. This has made OCT an essential tool to manage antiangiogenic treatment of macular oedema in diabetic patients. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008081-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/urn:x-wiley:14651858:media:CD008081:CD008081-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_t/tCD008081-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Results from searching for studies for inclusion in the review." data-id="CD008081-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Results from searching for studies for inclusion in the review.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008081-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/urn:x-wiley:14651858:media:CD008081:CD008081-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_t/tCD008081-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study" data-id="CD008081-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008081-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/urn:x-wiley:14651858:media:CD008081:CD008081-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_t/tCD008081-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of OCT for detection of CSMO." data-id="CD008081-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of OCT for detection of CSMO.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008081-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/urn:x-wiley:14651858:media:CD008081:CD008081-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_t/tCD008081-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Summary ROC Plot of OCT for detection of CSMO." data-id="CD008081-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Summary ROC Plot of OCT for detection of CSMO.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008081-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/urn:x-wiley:14651858:media:CD008081:CD008081-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_t/tCD008081-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of OCT for detection of DMO." data-id="CD008081-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of OCT for detection of DMO.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008081-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/urn:x-wiley:14651858:media:CD008081:CD008081-TST-001" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_t/tCD008081-TST-001.xxx" target="_blank"><b></b></a></p> </div><img alt="OCT for detection of CSMO." data-id="CD008081-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-TST-001.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 1</div> <div class="figure-caption"> <p>OCT for detection of CSMO.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/references#CD008081-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-TST-001.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008081-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/urn:x-wiley:14651858:media:CD008081:CD008081-TST-002" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_t/tCD008081-TST-002.xxx" target="_blank"><b></b></a></p> </div><img alt="OCT for detection of DMO." data-id="CD008081-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-TST-002.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 2</div> <div class="figure-caption"> <p>OCT for detection of DMO.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/references#CD008081-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/media/CDSR/CD008081/image_n/nCD008081-TST-002.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008081-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Optical coherence tomography (OCT) for diagnosing clinically significant diabetic macular oedema</span></div> <tbody> <tr class="table-header separated"> <td align="" class="table-header" colspan="3" rowspan="1" valign=""> <p><b> Optical coherence tomography for detection of macular oedema in patients with diabetic retinopathy</b> </p> <p><b>The presentation of the following results assumes that fundus photography or biomicroscopy are valid reference standards for diagnosing diabetic macular oedema (DMO). Readers should be aware of the fact that additional information offered by OCT regarding retinal thickness with respect to the reference standard is useful, specifically for false positives or subclinical DMO, a condition that was found to increase the risk of developing clinically significant macular oedema (CSMO).</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="3" rowspan="1" valign=""> <p><b> Patients or population: patients affected by diabetic retinopathy. Setting: referral eye clinics<br/> IndexTest: optical coherence tomography.<sup>1</sup> Reference Test: stereoscopic fundus photography or contact lens or non‐contact lens biomicroscopy of the fundus. Threshold: proven or probable CSMO based on ETDRS definition</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Test result</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of results</b> <br/> <b>per 1000 patients tested</b> (95% CI) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality</b> <br/> <b>of the evidence</b> <br/> <b>(GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="3" rowspan="1" valign=""> <p><b> Median prevalence 500 per 1000, which is typically seen in patients with diabetes of 15 to 20 years duration since diagnosis, older patients, and patients with additional risk factors.</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>All studies (697 participants, 1242 eyes, 9 studies)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b> 0.81 (0.74 to 0.87)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True positives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>403 per 1000</b> (371 to 428 per 1000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p>Low<sup>2, 3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False negatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>98 per 1000</b> (72 to 129 per 1000) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Specificity (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b> 0.85 (0.75 to 0.91)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True negatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>424 per 1000</b> (374 to 456 per 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False positives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>77 per 1000</b> (44 to 126 per 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Footnotes:</b> </p> <p><sup>1</sup><b>Note:</b> Index Test was OCT 2000 in 2 studies, Stratus in 5 studies, and Cirrus OCT in 2 studies using cut‐off retinal thickness 230 μm to 300 μm. </p> <p><sup>2</sup><b>Risk of bias (‐1):</b> patient selection and missing data were of concern in most studies. </p> <p><sup>3</sup><b>Imprecision (‐1)</b>: unit of analysis issues (eyes v. individuals) may bias precision. </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="3" rowspan="1" valign=""> <p><b> Low prevalence 100 per 1000, which is typically seen in patients with diabetes of 5 to 10 years duration since diagnosis and no other risk factors.</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Estimates at prevalence less than 50% (19% to 40%: 4 studies)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b> 0.74 (0.68 to 0.86)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True positives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>74 per 1000</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="5" valign=""> <p>Very low<sup>2, 3, 4</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False negatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>26 per 1000</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Specificity (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b> 0.92 (0.87 to 0.97)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>True negatives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>828 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>False positives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>72 per 1000</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>CI:</b> Confidence interval, <b>OCT</b> : Optical coherence tomography, <b>ETDRS</b>: Early Treatment Diabetic Retinopathy Study </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><sup>1</sup><b>Note:</b> Index Test was OCT 2000 in 2 studies, Stratus in 5 studies, and Cirrus OCT in 2 studies using cut‐off retinal thickness 230 μm to 300 μm. </p> <p><sup>2</sup><b>Risk of bias (‐1):</b> patient selection and missing data were of concern in most studies. </p> <p><sup>3</sup><b>Indirectness (‐1)</b>: low‐prevalence subgroup estimate is far from values expected in primary care. </p> <p><sup>4</sup><b>Imprecision (‐1)</b>: unit of analysis issues (eyes v. individuals) may bias precision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Optical coherence tomography (OCT) for diagnosing clinically significant diabetic macular oedema</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008081-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Subgroup analyses</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Covariate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Subgroup</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N studies</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall P values vs no subgroups</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Retinal thickness</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≤ 250 µm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86 (0.76 to 0.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (0.75 to 0.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 250 µm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77 (0.69 to 0.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (0.64 to 0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.971</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.034</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Prevalence</b> </p> <p><b>(</b><a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. "><b>Medina 2012</b> </a><b> in high prevalence group)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≥ 50% (50% to 65%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86 (0.81 to 0.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74 (0.64 to 9.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 50% (19% to 45%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74 (0.68 to 0.80)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (0.84 to 0.97)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.011</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Prevalence</b> </p> <p><b>(</b><a href="./references#CD008081-bbs2-0007" title="MedinaFJ , CallenCI , RebolledaG , Munoz‐NegreteFJ , CallenMJ , delValleFG . Use of nonmydriatic spectral‐domain optical coherence tomography for diagnosing diabetic macular edema. American Journal of Ophthalmology2012;153(3):536‐43. "><b>Medina 2012</b> </a><b> in low prevalence group)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 50% (56% to 65%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86 (0.81 to 0.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 (0.57 to 0.83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≤ 50% (19% to 50%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.74 (0.69 to 0.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (0.84 to 0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.109</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Reference standard</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Biomicroscopy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.78 (0.69 to 0.86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.79 to 0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Photography or both</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 (0.74 to 0.88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79 (0.64 to 0.89)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.653</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Subgroup analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/full#CD008081-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008081-tbl-0003"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p>Test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">1 OCT for detection of CSMO <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1303</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">2 OCT for detection of DMO <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008081.pub3/references#CD008081-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008081.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD008081-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008081-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD008081-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ru#CD008081-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008081\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008081\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008081\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008081\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008081\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=na56WA6j&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008081.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008081.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008081.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008081.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008081.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724238696"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008081.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724238700"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008081.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e5df2cbbff409',t:'MTc0MDcyNDIzOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 